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ABSTRACT 
Stroke is a cardiovascular disease that results in the abnormal blood supply to the brain either 
by the lack thereof (i.e., ischemia), or hemorrhage, both causing a rapidly developing loss of 
brain function.  It affects millions of people worldwide, resulting in long-term disability and 
death.  This work is an effort to reduce the morbidity and mortality rates associated with 
stroke through the implementation of shape memory materials in the design of medical 
devices used in its treatment and prevention. 
 
Shape memory materials have the ability to recover predetermined deformation upon 
exposure to stimuli such as heat.  These volume changing capabilities make them excellent 
candidate materials for stroke interventions.  Such interventions require the accessing of 
blood vessels in the brain, which over the past fifty years has shifted from a direct surgical 
approach, to less invasive endovascular procedures.   
 
The majority of this work is devoted to developing an endovascular thrombectomy device for 
the treatment of acute ischemic stroke.  This device evolves from a SMP-based device into a 
hybrid device made of a combination of SMP foam and nitinol.  The respective increase in 
success rate of thrombus removal in a bench-top model was from 67% to 100%.  This hybrid 
device is then tested in a porcine model, in which it is able to restore blood flow in an artery 
occluded with a thrombus nearly 3 times its working length.   
 
In addition to being utilized as a component of the hybrid thrombectomy device, SMP foam 
is being investigated as an embolic aneurysm filler for the prevention of hemorrhagic stroke 
 iii 
 
 
because of its flow arresting properties.  The rest of this dissertation deals with the 
characterization of such properties through the implementation of porous media theory.  A 
system is constructed for the measurement of the porous media properties of SMP foam as 
well as coils mimicking the geometry of embolic coils, which are the state-of-the-art 
treatment of aneurysms.  Results show that SMP foams impose a higher resistance to fluid 
flow compared to mock embolic coils, suggesting that aneurysms treated with SMP foams 
will have flow conditions more favorable for blood stasis than those treated with embolic 
coils.  
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NOMENCLATURE 
BPA  Bisphenol A ethoxylate diacrylate 
BzMA  Benzyl methacrylate 
C  Form factor (m
-1
) 
CNC  Computer numerically controlled  
DMA  Dynamic mechanical analysis 
DMPA  2,2-dimethoxy-2-phenylacetophenone 
DSC  Differential scanning calorimetry 
f  Friction factor  
FDA  Food and Drug Administration 
FHDD  Forchheimer-Hazen-Dupuit-Darcy 
GDCs  Guglielmi detachable coils 
ISA  Intracranial saccular aneurysm 
K  Permeability (m
2
) 
LLNL  Lawrence Livermore National Laboratory 
MEC  Mock embolic coil 
  
  
  Pressure gradient across porous medium (Pa/m) 
PMMA Polymethylmethacrylate 
PTFE   Polytetrafluoroethylene 
Q  Volumetric flow rate (m
3
/s) 
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Re  Reynolds number  
SEM  Scanning electron microscopy 
SMA  Shape memory alloy 
SMP  Shape memory polymer 
SNF  Shape memory nitinol flower 
Tg  Glass transition temperature (  C) 
tPA  Tissue plasminogen activator 
v0  Darcy velocity (=Q/cross-sectional area of sample) (m/s) 
η  Mock embolic coil packing density (%) 
µ  Dynamic viscosity of working fluid (Pa·s) 
ζ Post-mechanical reticulation hole density of shape memory polymer foams  
(E+05 holes/m
2
) 
ρ  Density of the working fluid (kg/m3) 
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CHAPTER I  
INTRODUCTION 
Stroke is a disease of the neurovasculature that affects 15 million people in the world each 
year, making it the second most common cause of death and the leading cause of adult long-
term disability [1-3].  Over the last century, its treatment shifted from a direct surgical access 
approach to a less invasive endovascular method, thanks to parallel growth in the fields of 
imaging and materials science [4, 5].  The endovascular method exploits the interconnected 
nature of our vascular system, which enables the delivery of drugs and navigation of devices 
via a catheter inside the blood vessels.  Therefore, the design and fabrication of 
neuroendovascular devices is challenging primarily because of the size constraints imposed 
by the catheter delivery of a device from the groin area to the brain.  Shape memory materials 
can exhibit the volume changes necessary for catheter delivery because they have the ability 
to store a temporary shape and recover their primary shape when exposed to a stimulus, 
which makes them ideal materials for neuroendovascular devices.  
  
While there has been progress in the endovascular treatment and prevention of stroke, areas 
of improvement remain.  The reason is because the mortality and morbidity rates, as well as 
the cost associated with this disease remain high.  In 2009, the U.S. indirect and direct costs 
due to stroke were estimated at $68.9 billion and increased to $73.3 billion by 2010 [6].  
General knowledge of the etiology, pathophysiology and complications of stroke is necessary 
to comprehend the need for improved neuroendovascular medical devices for its treatment 
and prevention. 
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Need for neuroendovascular medical devices: stroke 
Stroke is the rapidly developing loss of brain function due to abnormal blood supply to the 
brain tissue.  It can be caused by a blockage in the blood flow resulting in ischemia—lack of 
oxygen and glucose supply—or by a hemorrhage.   Depending on the cause, stroke is 
classified into two types: acute ischemic stroke and hemorrhagic stroke.  
 
Acute ischemic stroke 
The loss of blood supply to the brain tissue due to a blockage in an artery of the 
neurovasculature by a thrombus or embolism is called acute ischemic stroke.  This type of 
stroke comprises 85% of all stroke cases in the U.S. [2, 7].  It is an etiological heterogeneous 
disease and common risk factors are hypertension, diabetes mellitus, hyper cholesterolemia, 
cigarette smoking, oral contraceptive and high alcohol intake, and for the most part, 
atherosclerosis [6, 8-10]. This heterogeneity renders young adults, ages between 15 and 45, 
also susceptible to this disease.  In fact, they comprise 2-12% of the cases in western 
countries.  The most common risk factors for this group are non-atherosclerotic 
vasculopathies, i.e., migrane, dissection of extracranial arteries, HIV, and drug abuse; 
cardioembolisms, e.g., due to mitral valve disease and patent foramen ovale; atherosclerosis 
and other hematological disorders [11].  Given that atherosclerosis is a major contributor to 
the pathophysiology of ischemic stroke, it is not surprising that infection and inflammation 
are also linked to ischemic stroke, particularly in younger populations [8].  Additionally in 
developing countries, neurocysticerosis, cerebral malaria, tuberculosis and infective 
endocarditis are infectious diseases considered to cause ischemic stroke [12]. 
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Approximately every minute in the U.S. a person experiences an ischemic stroke each year. 
Of all cases, 8-12% are fatal. Of those who survive, 50% have some hemiparesis, 30% are 
unable to walk without assistance, 19% have aphasia, and 26% are institutionalized [6].  The 
degree of brain damage is strongly related with the amount of time that the brain is in 
ischemic state.  For example, each hour the ischemic brain remains untreated, it loses as 
many neurons as in 3.6 years of normal aging [13].  Likewise, the success of the treatment by 
the only drug approved by the Food and Drug Administration (FDA), tissue plasminogen 
activator (tPA), is limited by time.  TPA can only be administered to those patients who 
arrive at the hospital within 4.5 hours of stroke onset.  Because of this treatment time window 
and other exclusion criteria, only 2-5% of the patients are eligible to receive it [14]. 
 
The limited patient eligibility for treatment with tPA is largely responsible for the need of 
mechanical thrombectomy devices.  More information about the history of these devices and 
the devices that are currently on the market will be provided in the following sections.  For 
now, let us finish our brief overview on stroke. 
  
Hemorrhagic stroke 
It is estimated that 5 to 15% of all strokes are caused by the rupture of intracranial aneurysms 
resulting in hemorrhagic stroke [15].  Intracranial aneurysms are vascular malformations 
characterized by abnormal dilatations of the intracranial arteries.  Depending on their shape, 
they can be classified into saccular or fusiform.  Intracranial saccular aneurysms (ISAs) 
account for 90% of all intracranial aneurysms and are balloon-shaped, while fusiform 
aneurysms take on an elongated spindle-shape [16].  Fusiform lesions usually remain 
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asymptomatic until they press on adjacent tissue. Saccular lesions, on the other hand, become 
symptomatic after they rupture resulting in spontaneous subarachnoid hemorrhage (SAH).  
Although the rupture potential of aneurysms is only between 0.1-1.0% per year, the 
consequences when they do rupture are devastating.  Approximately 35 to 50% of the 
patients die, and of those who survive, 50% regain functional independence, while 30% are 
permanently disabled and 20% require institutional care [17-19].  Because there is a much 
higher prevalence and fatality rates associated with saccular lesions compared to fusiform 
lesions, the remainder of this work will primarily focus on ISAs. 
 
ISAs develop in or near bifurcations of the primary network of arteries that supply the brain 
with blood, called the circle of Willis.  The majority form in the anterior circulation, 
particularly in the anterior communicating artery, the internal carotid artery at the posterior 
communicating artery origin and the middle cerebral artery (MCA) bifurcation.  The most 
common site in the posterior circulation is the basilar artery bifurcation [20].   
 
There is little agreement on the pathogenesis of ISAs; however, major role players are: 
distinct geometrical features of the cerebral vasculature, genetic and environmental risk 
factors and hemodynamics.  The most relevant geometrical features of the cerebral arteries 
that may contribute to the initiation of ISAs are the lack of an external elastic lamina, scarcity 
of elastin in the media, and structural irregularities at the apex of vessel bifurcations [20].  
Among the environmental and genetic risk factors are hypertension, smoking, and gender.  
Finally, hemodynamics plays a role in the growth and remodeling of ISAs because it affects 
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mainly the regulation of protease activity and collagen production within the aneurysm wall 
[18, 21-23].  
 
With a general understanding of the causes and consequences of stroke, we will move onto a 
brief history of the devices that have been developed in an attempt to treat and prevent this 
disease.   
 
History and evolution of thrombectomy and filling devices 
The surgical treatment of vascular lesions of the head and neck began in the early 20
th
 
century.  This was a time during which an array of different treatment techniques were 
attempted [4].  Some techniques were more successful than others; however, all of them in 
some way laid the groundwork for the conception and development of the devices that are 
used today.   
 
The beginning of the 20
th
 century was marked by the development of different clips coated 
with thrombogenic materials intended to slowly occlude the patent vessel of a vascular 
malformation (i.e., cerebral aneurysm, fistula or arteriovenous malformation) to prevent its 
future rupture.  The Neff clamp, developed in 1904, was one of such first devices.  The main 
feature of this de ice  as that the clamp’s rubber bands,  hich  ere responsible for the 
squeezing action, were coated with absorbable catgut for a slow yet progressive occlusion of 
arteries [4, 24].  While this de ice intended to isolate the  ascular malformation by “e tra” 
vascular means (i.e., clipping), there were also efforts to achieve this by surgical “intra” 
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vascular means (i.e., filling).  The first such attempt took place in 1930 when Brooks 
implanted harvested muscle inside a carotid-cavernous fistula.  This procedure laid the 
foundation for the much later development and progression of surgery that was more focused 
on less invasive and intravascular approaches [25].  However, until then, clamping methods 
continued to be developed.  In 1937 Walter Dandy placed a silver clip at the base of an 
aneurysm, an effort which marked a new era in the surgical treatment of cerebrovascular 
malformations [26, 27]. 
 
While surgical clipping became the standard for the treatment of cerebral aneurysms, much 
work was done to find alternative ways of embolizing vascular malformations similar to 
Brooks’ attempt.  By the 1960s, different particulates and materials had been explored as 
potential filling agents, ranging from methylmethacrylate spheres and metal pellets to horse 
hair [28-30].  Additionally, the feasibility of utilizing magnets for the endovascular 
navigation of metallic pellets as well as the use of direct current for thrombosis were 
explored [31-35].      
 
Up until this point, significant advancements had been made in the development of devices 
and treatment methods for vascular malformations such as aneurysms, fistulae and 
arteriovenous malformations.  On the contrary, this was not the case for the development of 
treatment techniques for cerebrovascular occlusions.  In 1961, Dr. Wolff, professor of 
Neurology, raised the following statement during the Princeton Conference on 
Cerebrovascular Disease [36]:  
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“ urgeons ha e made rapid and dramatic ad ances in the treatment of people  ith 
occlusive vascular diseases in the upper chest and neck.  Perhaps we could encourage 
them to think of ways of going inside the head and modifying the circulation there, 
for at present even those individuals who have occlusive disease in the vertebral canal 
are not surgically approachable ”  
 
The concept of revascularization (i.e., the re-establishment of blood flow in an occluded 
vessel) was introduced in the early 1950s, when Dr. Henschen, professor of Surgery at the 
University of Basel in Switzerland, transplanted a graft of temporalis muscle to the cerebral 
cortex of a patient with bilateral carotid stenosis [37].  The years that followed were marked 
by numerous attempts of revascularizing ischemic areas of the brain by different surgical 
means.  Examples include the development of collateral circulation by a graft, the reversal of 
cerebral circulation by carotid-jugular anastomosis, and the resection of the thrombosed 
portion of the vessel followed by its replacement by a vascular graft [38].  Unfortunately, all 
of these surgical approaches had little success, suggesting that the missing link in the 
successful surgical treatment of cerebrovascular occlusions was the ability to access occluded 
vessels by means of endovascular navigation.   
 
Endovascular navigation was not possible until the capability to visualize the vascular tree in 
real time was available.  Therefore, it is not surprising that true catheter-based approaches did 
not begin until the 1960s, when catheter-cerebral angiography was brought to America, 
nearly thirty years after being developed in Europe [4, 39, 40].  This decade was a 
revolutionary period of great technological advancements in endovascular neurosurgery.   
In the following decades, the endovascular approach became the gold standard for the 
treatment of cerebrovascular lesions.  However, specifically for the revascularization of 
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thrombotic occlusions, this did not happen until the early 21
st
 century.  The 1970s was 
characterized by the competency to highly purify proteins for biochemical studies, which 
enabled the exploration of biochemical means of dissolving thrombi, also known as 
thrombolysis.  Although it was known since 1947 that animal tissues contain an agent that 
can activate plasmin, it was not until the late 1970s that tPA was discovered to be fibrin-
specific.  This rendered tPA as superior compared to other available non fibrin-specific 
plasmin activators (e.g., urokinase and streptokinase) for thrombolytic therapy, given that 
thrombi are rich in fibrin [41].  Based on these facts and numerous other clinical studies, the 
FDA approved tPA in 1996, and up to date, it remains as the only FDA-approved drug for 
the treatment of acute ischemic stroke [42].   
 
The treatment of vascular malformations on the other hand, never took a pharmacological 
route.  Instead, the area of exploration focused on endovascular filling devices.  A major 
breakthrough in the history of endovascular filling devices was the insertion of platinum coils 
into a cerebral aneurysm in the late 1980s by Hilal et al. [43].  This technique was modified 
by Guido Guglielmi, who collaborated with Target Therapeutics to launch the first 
generation of electrolytically detachable coils, also known as Guglielmi Detachable Coils, 
(GDCs) in 1990 [4].  GDCs are still in the market and they are the precursors of the multiple 
variations of embolic coils that are commercially available up to present.  
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Current thrombectomy and filling devices 
Current thrombectomy devices used in the neoruvasculature and peripheral circulation can be 
classified into 5 major types: snare devices (e.g., Amplatz Goose Neck Snare, ev3, 
California), laser-based systems (e.g., Endovascular Photo-Acoustic Recanalization System, 
EndoVasix Inc., California), ultrasound-based devices (e.g., MicroLysUs Catheter, EKOS 
Corp., Washington), retrieval devices (e.g., Merci Retriever®, Stryker, California), and 
aspiration devices (e.g., AngioJet, Possis Medical Inc., Minnesota).  Some use a combination 
of two or more types, like the Penumbra System® (Penumbra Inc., California), which 
mechanically disrupts and aspirates the fragmented thrombus [2].  The majority of these have 
not made it past the research and development stage, and some are used off-label.   
 
The first thrombectomy device to get cleared by the FDA for the treatment of acute ischemic 
stroke was the Merci Retriever® in 2004.  This device primarily consists of a nitinol wire of 
approximately 50 mm in length, with a pre-programmed corkscrew shape.  Its 510(k) 
application was based on a series of devices that in turn, were cleared based on substantial 
equivalence to precursor devices.  Some of these precursor devices include the Concentric 
Retriever (Concentric Medical, California) and the Attractor Endovascular Snare (Target 
Therapeutics, California), both intended for the removal of emboli and foreign bodies in 
distal peripheral vessels [44].  Four years after the launch of the Merci Retriever®, a second 
device got 510(k) clearance.  This device was the Penumbra System®, which consists of a 
separator at the tip that disrupts the thrombus as it is moved back and forth, and suction 
applied to the catheter to aspirate the thrombus fragments.  The devices that followed were 
very different from the aforementioned ones, primarily because they took on a stent-like 
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shape.  These were the Solitaire
TM
 FR (ev3, California) and the Trevo® (Stryker, California), 
which were cleared to market in 2012.  Both of these are self-expandable nitinol stents 
roughly 30 mm long. 
 
Stents are not only used in the treatment of acute ischemic stroke, but they are also used to 
treat hemorrhagic stroke.  They are usually placed in the parent artery across the neck of the 
aneurysm, generally when the aneurysm has a wide neck (i.e., when the aneurysm neck 
opening diameter is greater than the dome diameter), either by themselves or along with an 
aneurysm filler [45].  Stents provide important stabilization to the parent vessel and to the 
filler as they prevent it from potentially migrating out of the aneurysm dome.  Examples of 
commonly used nitinol stents for this application include the Neuroform
TM
 (Stryker, 
California), the Enterprise
TM
 (Cordis, Florida), and the Wingspan
TM
 (Stryker, California). 
 
There are different types of aneurysm fillers, including embolic liquids (e.g., Onyx®, ev3, 
California), embolic particles (e.g., Embozone® Microspheres, CeloNova Biosciences, 
Texas), and embolic coils.  Helical platinum coils are now the standard for endovascular 
treatment of aneurysms and other malformations [5].  When the first version of platinum 
embolic coils were developed, platinum was the material of choice primarily because of its 
sensitivity to low electrical current, which made them easily detachable from steel 
guidewires.  Additional reasons were that platinum is a soft metal that can be easily bent, it 
has been shown to recover its shape, and is biocompatible when implanted [46].  However, 
significant changes have been made to the design of embolic coils in order to increase 
treatment success rates.  Some of these changes involve the design of non-helical, complexly 
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shaped coils (e.g., GDC® 360  (Stryker, California)) and the addition of polymer coatings in 
order to increase the bioactivity of the coils and their filling capacity.   
 
Despite the improvements that have been made to embolic coils up to date, there are still 
challenges and complications that arise from their use in the treatment of aneurysms.  The 
most important are impartial filling of the aneurysm resulting in low coil packing densities, 
coil compaction over time, and coil migration to the parent artery [47-49].  For example in 
aneurysms with diameter greater than 10 mm the maximum packing density is usually below 
24% [50].  Likewise, the thrombectomy devices that are commercially available have 
limitations.  Major ones are poor device flexibility and thrombus hold during thrombectomy, 
but more importantly, restricted placement due to the length of some devices required to be 
advanced past the thrombus [2, 51-53].  In order to overcome these challenges, researchers 
are investigating shape memory materials with superior volume expansion capabilities than 
the ones that are used in available devices up to date.  In the next section, a general overview 
of what shape memory materials are is given, and the two shape memory materials that were 
used in the devices presented in this work are introduced. 
 
What are shape memory materials? 
Shape memory materials, or smart materials, possess the ability to store a temporary shape(s) 
and then actuate to a primary geometry upon exposure to stimuli such as electric field 
changes, heat or moisture [54-58].  This phenomenon is called the shape memory effect, and 
it is exhibited by certain classes of ceramics, alloys and polymers. In ceramics, such as the 
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ones based on antiferroelectric lead zirconate titanate for example, the shape memory effect 
is triggered by electric field-induced phase transitions. Shape memory ceramics generate 
recovery forces of roughly 100 MPa and are characterized by responses on the order of 
miliseconds and strains on the order of 10
-3
 mm/mm [57]. Thus, these materials are excellent 
candidates for applications requiring a fast response and only one small strain state such as 
for latching relays, where the ceramic is capable of maintaining the “on” state even without 
the recurring application of electricity [57].  
 
Shape memory alloys (SMAs) have two phases that correspond to the structure of their 
atoms. The first one is the high-temperature austenite or parent phase (characterized by a 
cubic crystal structure) and the second one is the low-temperature martensite phase with a 
lower symmetry.  The atomic movement from one phase to the other triggered by 
temperature and stress changes is what results in the shape memory effect in these type of 
smart materials.  Phase transformation takes place when the free energy difference between 
the two phases reaches a critical value [58].  When the temperature of the SMA decreases 
below its martensitic transformation temperature, the atoms move in a cooperative and shear-
like manner resulting in the so called martensitic transformation.  As a result, the crystal 
structure changes into the twinned configuration.  If a load is applied to the material in the 
twinned configuration while at a low temperature, detwinning occurs and the material retains 
its deformed (or secondary) shape even after the load is removed.  If the material is heated to 
a temperature above the austenitic transformation temperature, the crystal structure returns to 
the parent phase and the original shape is recovered [58].  
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In addition to the shape memory effect, SMAs also possess pseudoelastic capabilities, i.e., 
the ability to transform from one phase to another as a result of induced stress at a constant 
temperature [57, 58].  When a load is applied to the SMA while in the austenitic phase (at a 
temperature above the martensitic transformation temperature), it can result in the direct 
transformation to the detwinned martensite if the induced stress is above a certain threshold.  
However, the martensite is not stable at temperatures above its transformation temperature, 
which is why when the load is removed, the crystal structure transforms back to the austenite 
and the original shape is recovered.  This effect is responsible for the ‘spring-like’ behavior 
of SMAs, which is limited by a maximum strain, above which plastic deformation occurs 
[59].  Examples of SMAs are AgCd, AuCd, CuAlNi, CuAlBe, CuSn, CuZn, NiAl, and NiTi.  
NiTi, also called nitinol in honor of the Naval Ordinance Laboratory (NOL) where it was 
discovered in the 1960s, is characterized by recoverable forces of approximately 1000 MPa 
and strains on the order of 10
-1
 mm/mm [57, 59]. 
 
The last type of smart materials that we include in this section are shape memory polymers 
(SMPs).  The term ‘polymer’ refers to a molecule made by repeating units of monomers   
Polymers are viscoelastic, which means that they exhibit the combined viscous and elastic 
responses of materials that behave intermediately between liquids and solids when a stress is 
applied, like Silly Putty [57, 60].  For example, when Silly Putty is formed into a ball and 
then left in a container for a long period of time, it will flow to conform to the shape of the 
container, dissipating energy (viscous response).  Conversely if it is rapidly stretched and one 
end is released, it will partially return to its original dimensions as a result of the temporary 
energy storage (elastic response) [60]. 
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Thermoplastic polymers with physical crosslinks and thermoset polymers with chemical 
crosslinks have the ability to exhibit shape memory [61].  When these materials are heated 
above their glass transition temperature (Tg), their polymer segments undergo conformational 
motion that enables mechanical deformation into a secondary metastable state when a load is 
applied [54, 56].  As the temperature is lowered, the rearranged intermolecular conformations 
are locked and the new shape is fixed.  Heating the material above Tg provides the system 
with activation energy that enables polymer chain mobility.  The polymer chains relax back 
to their original geometry in an attempt to minimize free energy, which results in the 
reco ery of the material’s primary shape [61].  SMPs are characterized by the ability to tune 
their thermomechanical properties to meet specific application demands. However, they have 
been reported to exhibit maximum recoverable forces less than 1/100 times those reported for 
SMAs, with maximum strains on the order of 10 mm/mm [54, 57, 61].  
 
The aforementioned properties of SMAs and SMPs make them excellent candidate materials 
for applications requiring high volume expansion and high recovery force.  One such 
application is the catheter delivery and subsequent actuation of the neuroendovascular 
devices developed in this work.  Thus, these devices benefit from the use of each, and the 
combination, of these two types of shape memory materials.  
 
Purpose of research 
Through this work we intend to contribute to the improvement of the neuroendovascular 
treatment and prevention of stroke via the characterization and implementation of SMPs and 
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SMAs as components of neuroendovascular devices.  The next two chapters document the 
design process of a thrombectomy device, which starts with a design involving SMP alone, 
and evolves to a hybrid design that explores the combination of SMP foam and SMA.  The 
penultimate chapter describes the experimental measurement of the porous media properties 
of the new SMP foam embolic aneurysm filler that is being developed in the Biomedical 
Device Laboratory for the treatment of ISAs. 
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CHAPTER II  
SMP THROMBECTOMY DEVICE 
In 2007, scientists at Lawrence Livermore National Laboratory (LLNL) developed a 
corkscrew-shaped thrombectomy device made of a commercially available thermoplastic 
SMP (MM5520, DiAPLEX Company, Ltd., a subsidiary of Mitsubishi Heavy Industries, 
Ltd., Tokyo, Japan).  The device was successfully delivered by a catheter, but encountered 
two problems upon testing in a rabbit animal model [62].  First, similar to previously 
mentioned commercially available devices, the portion of the device required to be advanced 
past the thrombus was too long and thus limited device access.  As a result, the same group at 
LLNL proposed a flower-shaped SMP thrombectomy device.  The new design reduced the 
deployment length to less than half of that required by commercially available mechanical 
thrombectomy devices [63].  However, the second problem was related to the recovery force 
of the corkscrew device, as it was not sufficient to achieve complete actuation when the 
device was pushed against the vessel wall.  
 
This chapter presents the results of a study in which a thrombectomy device, modeled after 
the flower-shaped design developed at LLNL, was fabricated from crosslinked thermoset 
acrylic SMP.  The goal was to evaluate different crosslink densities to tailor the 
thermomechanical properties that would result in the highest achievable recovery force.   
 
Introduction 
While the SMP-based flower-shaped thrombectomy device exhibited limited recovery force, 
the ability to tune the thermomechanical properties including modulus and recovery stress of 
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SMPs offered a solution to this problem.  One effective, demonstrated way of tailoring 
thermomechanical properties of SMPs is controlling crosslink density [64, 65].  Increasing 
crosslink density of SMP systems has been generally shown to increase recovery stress, 
which is desirable for thrombectomy devices because it reduces the likelihood of incomplete 
shape recovery, which could result in thrombus dislodgement [56, 66, 67].  Acrylate 
assemblages provide a stable backbone that allows the incorporation of chemical crosslinks 
into the polymer matrix by varying the ratio of linear builder (monofunctional monomer) to 
crosslinker (multi-functional monomer).  However, the caveat of increasing crosslink density 
for this type of materials is that it also results in unfavorable changes such as increased 
brittleness and decreased strain capacity [64].   
 
The objective of this study was to fabricate a set of SMP-based thrombectomy devices that 
offered improved access and thrombus hold than comparable available devices.  To improve 
device access we selected a design that reduced the length required to go beyond the 
thrombus, such as the flower-shaped design developed at LLNL [63].  We incorporated 
chemical crosslinks into the polymer structure to improve thrombus hold via increasing the 
device recovery stress.  However, increases in recovery stress come at the expense of reduced 
strain capacity, which is particularly important for devices that undergo large deformations.  
For our desired applications, these large deformations were required for catheter delivery, 
and consisted of crimping the device to a cylindrical shape and then actuating it back to its 
primary flower-shape.  Since arteries of stroke patients are generally diseased and therefore 
stiffer than healthy arteries, we tested the recovery force of the devices under constrained 
conditions.  As such, this work investigates the thermomechanical performance of the 
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devices with various material properties during crimping and constrained recovery.  We took 
the following approach: 
i. Designed a system of cross-linked acrylate SMPs with varying rubbery moduli; 
ii. Machined devices and measure the forces required for crimping and constrained 
recovery; and 
iii. Performed thrombus removal experiment in a bench-top thrombotic model to determine 
the success rates of the proposed devices. 
 
Materials and methods 
All the devices have the same design, which is illustrated in Figure 2.1.  After thrombectomy 
devices were CO2 laser machined, they were subjected to custom device-specific 
experiments, in which the forces required to crimp the devices at two temperatures (DMA 
loss modulus peak, theoretical maximum toughness, and tan delta peak, theoretical maximum 
strain) and the recovery forces of the devices under constrained conditions were measured 
[60, 68].     
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Figure 2.1.  Drawing of the flower-shaped thrombectomy device designed in SolidWorks 
(dimensions are in mm). 
 
 
Polymer synthesis 
We prepared four thermoset acrylic copolymers containing the monomer benzyl methacrylate 
(BzMA), the crosslinker bisphenol A ethoxylate diacrylate (Mn~512, BPA), and the 
photoinitiator 2,2-dimethoxy-2-phenylacetophenone (DMPA).  All three chemicals were 
purchased from Sigma Aldrich and used as received without further purification.  This 
monomer and difunctional crosslinker combination, which is similar to that reported by 
Safranski, et al. (2008), was selected because it enables the synthesis of a series of SMPs 
with tailorable crosslink densities and glass transitions above body temperature in the range 
of 65 to 75  C.  BzMA was also selected because Safranski, et al. demonstrated that 
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poly(benzyl methacrylate) thermoset SMPs have higher toughness than numerous other 
thermoset acrylics [69].  
 
The four compositions contained 5, 15, 25 and 35 mole % BPA and 0.5 wt. % DMPA and 
were prepared in 51×76×0.4 mm sheets by bulk UV curing.  After massing, the monomer, 
crosslinker and photoinitiator mixtures were injected between 51×76 mm glass slides coated 
with Rain-X and separated by 0.4 mm spacers.  These slides were cured for 99 minutes using 
365 nm UV irradiation inside a UVP CL-1000 crosslinking chamber.  The cured thermoset 
films were then post-cured at 130  C with vacuum at 1 torr for 12 hours and subsequently 
stored under desiccation. 
 
Dynamic mechanical analysis 
Dynamic Mechanical Analysis (DMA) experiments were carried out in tension using a TA 
Instruments Q800 dynamic mechanical analyzer in 4×30×0.4 mm rectangular speciments 
(n=5).  The rectangular specimens were machined with a 40 W Gravograph LS100 CO2 laser 
machining device using a 38.1 mm lens, a speed setting of 5, a power setting of 10, and a 
laser resolution of 1200 dots per inch.  Specimens were cleaned with a methanol damp 
Kimwipe and dried at 90  C prior to being tested and subsequently stored under desiccation.  
DMA experiments were carried out from -20 to 140  C in the DMA Multi-Frequency/Strain 
instrument mode utilizing a frequency of 1 Hz, a strain of 0.1%, a preload force of 0.01 N, a 
force track of 150%, and a heating rate of 2 C  /min.  Data were recorded using TA 
Instruments Q-series software and analyzed using TA Instrument Universal Analysis 
software. 
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Tensile testing 
Uniaxial tensile testing experiments were conducted to failure on ASTM Type V dog bone 
samples (n=5) using a dual-column Instron model 5965 tensile tester with a 500 N load cell, 
1000 N high temperature pneumatic grips, and a temperature chamber thermally controlled 
by forced convection heating.  The dog bone samples were cut using the Gravograph LS100 
CO2 laser cutter with the same instrument parameters used in the machining of DMA 
specimens.  Specimens were cleaned with a methanol damp Kimwipe and dried at 90  C 
under vacuum at 1 Torr prior to being tested and subsequently stored under desiccation.  
Specimen deformation was measured optically using an Instron Advanced Video 
Extensometer with a 60mm field-of-view lens.  Specimens were heated to target 
temperatures under zero load (unclamped bottom grip) and held isothermally for 30 minutes 
to allow for thermal equilibrium to be reached.  The bottom grip was then clamped, and the 
strain-to-failure experiments were subsequently begun using a deformation rate of 10 
mm/min.  Data were recorded utilizing Instron Bluehill 3 software.  
 
Device fabrication 
The post-cured 51×76×0.4 mm sheets of the four different copolymers were cut with the 
flower-shape design pattern (Figure 2.1)  using the Gravograph CO2 laser machining device 
with the same parameters used to cut the DMA specimens.  Machined devices were carefully 
cleaned with a methanol damp Kimwipe and dried at 90  C under vacuum at 1 Torr prior to 
being tested, and subsequently stored under desiccation. 
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Device crimping 
A custom fixture compatible with the Instron tensile tester was fabricated with a mini 
computer numerically controlled (CNC) milling machine (MDX540, Roland).  As depicted 
in Figure 2.2, it consisted of a removable portion fabricated from polytetrafluoroethylene 
(PTFE) with a funnel-like geometry on the inside, and a stationary portion made of 
poly(methyl methacrylate) (PMMA) that attached to the bottom pneumatic grip of the tensile 
tester.  The maximum diameter of the funnel was 12.5 mm and it contracted gradually to 3.5 
mm (the portion with the smallest diameter is 1 cm long and served to fit the crimped device 
and allow it to cool down).  The stationary portion had a cap with a 0.3 mm hole machined 
with an excimer laser (RapidX, Resonetics) that helped center the wire that held the devices 
throughout the crimping process.  This wire had roughly a 2 mm diameter ball of 96.5 Sn 3.5 
Ag solder (Indium Corporation) at the tip to hold the devices as they were pulled during 
crimping.  By inserting a thermocouple inside the funnel of the assembled crimping fixture, it 
was determined that in order to achieve the target temperature inside the funnel within 45 
minutes, the temperature chamber was required to be set 4  C higher.  Thus, devices were 
allowed to thermally equilibrate inside the funnel for a minimum of 1 hour prior to testing.  
The tensile tester had a 50 N load cell (resolution of 0.00025 N) and was set to extension 
mode at a strain rate of 5 mm/min.  Data were recorded using Instron Bluehill 3 software.  
The crimping experiments were performed at temperatures corresponding to the mechanical 
transition temperature of each copolymer’s composition (n=5). 
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Figure 2.2. Sketch of custom-made apparatus for crimping compatible with Instron tensile 
tester (not drawn to scale). The device is inserted in the PTFE insert through the funnel, and as 
it is displaced upwards by the crosshead, it gets crimped to a cylindrical shape. 
 
 
Device constrained recovery 
A radial tensile tester (Blockwise Engineering), also compatible with the Instron tensile 
tester, was utilized to perform constrained recovery measurements of the crimped devices 
(see Figure 2.3).  The radial tester temperature was ramped from 30  C to 55  C and the 
recovery force of the devices that had been successfully crimped was measured at 1 Hz using 
Instron Bluehill 3 software.  A thermocouple was installed in close proximity of each device, 
and temperature was also recorded at 1 Hz using LabView.  The diameter of the radial tester 
was kept constant at 3.75 mm after setting it with a high accuracy gage pin.  The blade 
heating effects of the radial tester were accounted for by subtracting data measured with the 
empty tester from the data of all devices for the same temperature range. 
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Figure 2.3. Sketch of Blockwise radial tester (not drawn to scale).  The crimped device is placed 
in the center of the blades.  As the temperature is ramped from ambient to 55  C, the recovery of 
the device applies a load on the blades which is sensed by the load cell to which the radial tester 
is connected. 
 
 
Bench-top thrombus removal 
Figure 2.4 shows the bench-top thrombotic stroke model that was constructed to test the 
feasibility of the SMP flower-shaped devices for thrombectomy.  The bovine thrombi that 
were utilized in the experiments were prepared following the protocol described by Gralla et 
al. (2006), with 10 ml of bovine blood acquired from Vet Med Park (College Station, TX), 1 
g of barium sulphate and 25 IU of bovine thrombin both purchased from VWR.  The mixture 
was injected into a silicone tube with 10 mm inner diameter, and gently agitated for 
approximately 1 minute.  Thrombi were subsequently incubated at room temperature 
overnight and were sliced with a scalpel into approximately 2 cm long pieces prior to the 
experiments [70].   
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Figure 2.4. Bench-top thrombotic stroke model constructed to test the feasibility of the SMP 
flower-shaped devices for endovascular thrombectomy. WB: water bath (37  C); PP: peristaltic 
pump; TT: tensile tester (extension rate= 75 mm/min); Q; experimental flow rate (=57 ml/min); 
TB: Touhy Borst valve; CD: crimped device location; VM: vessel model; TP: thermocouple 
probe; HW: hot water syringe; DV: discharge valve; DC: discharge container.  
 
 
Each crimped device and a thrombus were inserted into the silicone bifurcated vessel model 
(Shelley Medical Imaging Technologies, Ontario, Canada) shown in Figure 2.4.  Water at 
37  C was pumped into the main vessel segment (lumen diameter= 8 mm) at a flow rate of 57 
ml/min via a peristaltic pump.  The in vivo dynamically similar flow rate that corresponds to 
the experimental flow rate is within the range of flow rates recorded in the MCA, a common 
site for thrombotic occlusion in the neurovasculature [71].  The device was actuated by 
injecting water near boiling temperature with a syringe while shutting the valve that connects 
one of the bifurcations of the vessel model to the discharge container.  The device was 
attached to a guidewire, which was connected to a tensile tester (MTS, Synergie) through a 
catheter.  The device was pulled at an extension rate of 75 mm/min in the direction contrary 
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to that of the flow, to remove the thrombus.  The temperature before and during actuation 
were recorded at 1 Hz by placing a thermocouple near the location of the device. 
 
Results 
Material properties of copolymers 
Plots of storage modulus, loss modulus and tan delta for the four copolymers containing 5, 
15, 25 and 35 mole % BPA in Figure 2.5(a-c) and numerical values for rubbery modulus, 
loss modulus peak temperatures and tan delta peak temperatures are provided in Table 2.1.  
Rubbery modulus values were taken at the minimum rubbery storage modulus points for all 
four chemical compositions.  As the crosslinker increased from 5 to 35 mole %, rubbery 
modulus increased from 1.6 to 15.6 MPa.  Loss modulus peak temperatures ranged from 50.8 
to 62.3  C, tan delta peak temperatures ranged from 61.5 to 72.3  C, and both mechanical 
transition temperatures decreased with increasing BPA crosslinker composition.  Strain-to-
failure experiments were carried out on samples of all four BPA compositions at both 
mechanical transition temperatures.  All stress-strain curves are shown in Figure 2.6, and 
average data of stress-at-failure, strain-to-failure, and toughness (i.e., the area under the 
stress-strain curves) are listed in Table 2.2.  For strain-to-failure experiments conducted at 
loss modulus peak temperatures, increasing the BPA crosslinker from 5 to 35 mole % 
resulted in an average stress-at-failure increase from 11.9 to 23.0 MPa and an average strain-
to-failure decrease from 1.43 to 0.47 mm/mm.  For strain-to-failure experiments conducted at 
tan delta peak temperatures, increasing BPA crosslinker composition resulted in an average 
stress-at-failure increase from 2.7 to 7.7 MPa and an average strain-to-failure decrease from 
1.41 to 0.37 mm/mm.  For both the loss modulus peak temperature and tan delta peak 
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temperature strain-to-failure series, toughness decreased as BPA composition was increased 
from 5 to 15 to 25 mole %, and then increased for the 35 mole % BPA samples.  One 
possible explanation for this increase in toughness for the most highly crosslinked samples is 
that bisphenol A groups ha e been sho n to be capable of undergoing π- π stacking, which 
increases toughness in materials such as poly(bisphenol A carbonate) [72].  It is possible that 
at high enough BPA compositions, π- π stacking became predominant enough to improve 
toughness.     
 
 
(a) 
 
 
 
 
 
 
 
 
 
Figure 2.5. Dynamic mechanical response of four copolymers, namely storage modulus (a), loss 
modulus (b) and tan delta (c).  By increasing the amount of crosslinker, the rubbery modulus 
(i.e., the lowest point of the storage modulus curve) also increases.  The temperatures at loss 
modulus and tan delta peak decrease as a result of increasing crosslinker composition. 
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(b)  
 
 
 
 
 
 
 
 
Figure 2.5. Continued. 
 
 
 
 
 
 
 
 
 
 29 
 
 
(c) 
 
 
 
 
 
 
 
 
 
Figure 2.5. Continued.                      
 
 
 
 
Table 2.1. Rubbery modulus and mechanical transition temperature values. 
Composition 
Rubbery modulus 
(MPa) 
Loss modulus peak 
temperature (°C) 
Tan delta peak 
temperature (°C) 
5% BPA 1.67  +  0.18 62.3  +  0.16 72.3 +  0.16 
15% BPA 5.92  +  0.08 53.6  +  0.17 66.9  +  0.16 
25% BPA 11.0  +  0.32 50.8  +  0.25 62.8  +  0.24 
35% BPA 15.6  +  1.02 50.8  +  0.11 61.5  +  0.12 
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(a) 
 
 
 
 
 
 
 
 
 
Figure 2.6. Tensile properties of the four copolymers measured at each copolymer’s loss 
modulus peak a) and tan delta peak b) temperatures.  For both temperatures, the effect of 
crosslinker percent on decreased strain capacity is evident.  Additionally, the response of all 
four compositions when tested at tan delta peak temperature is more brittle than the response 
when tested at loss modulus peak temperature. 
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(b) 
 
 
 
 
 
 
 
 
 
Figure 2.6. Continued. 
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Table 2.2. Average stress-at-failure, strain-to-failure, and toughness at loss modulus peak and 
tan delta peak temperatures. 
 
Composition 
 
Strain-to-failure 
(mm/mm) 
 
Stress-at-failure 
(MPa) 
 
Toughness 
(MJ/m
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 5% BPA   1.43 + 0.0985 
 
11.9 + 2.14 
 
8.99 + 1.72 
15% BPA 
 
0.773 + 0.0906 
 
14.2 + 1.51 
 
6.21 + 0.992 
25% BPA 
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13.2 + 1.07 
 
3.96 + 0.747 
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 5% BPA 
 
1.41 + 0.254 
 
2.75 + 0.338 
 
1.49 + 0.296 
15% BPA 
 
0.590 + 0.182 
 
2.87 + 0.254 
 
0.697 + 0.169 
25% BPA 
 
0.357 + 0.0354 
 
4.09 + 0.251 
 
0.647 + 0.0723 
35% BPA 
 
0.376 + 0.0879 
 
7.73 + 1.56 
 
1.24 + 0.316 
 
 
Device crimping 
A total of five devices were crimped for each of the four BPA compositions at their 
corresponding loss modulus peak and tan delta peak temperatures.  Figures 2.7(a) and 2.8(a) 
show plots of force versus extension during crimping at loss modulus peak and tan delta peak 
temperatures, respectively.  Figures 2.7(b) and 2.8(b) show images of the top, side, and 
bottom views of crimped 35 mole% BPA devices at the two respective crimping 
temperatures.  The crimping temperature had a significant effect on both the magnitude of 
the force required for crimping and on the propensity for device failure during crimping.  For 
devices crimped at loss modulus peak temperature, the maximum average crimping force 
increased from 0.10 to 0.58 N as BPA composition increased from 5 to 35 mole %.  None of 
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the devices crimped at loss modulus peak temperature failed upon crimping.  On the 
contrary, the devices crimped at tan delta peak temperature were much more susceptible to 
failure: for the 5, 15, 25 and 35 mole % BPA samples, the number of devices that failed 
when crimped at this temperature was 1, 2, 3 and 5 respectively.  Most failure locations 
consistently occurred at the base of the devices, and appeared to initiate at the edges of the 
center holes, as shown in Figure 2.8(b). 
 
Device constrained recovery 
Because of the significant device failures that occurred during crimping at tan delta peak 
temperatures, only devices crimped at loss modulus peak temperatures were subjected to 
constrained recovery tests.  Five devices were tested for each BPA composition.  In Figure 
2.9, plots of average recovery stress versus temperature are shown for devices with varying 
BPA composition.  As BPA composition increased from 5 to 35 mole %, average recovery 
stress increased from 0.526 to 12.2 kPa.   
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Figure 2.7. Force measurements of devices crimped at loss modulus peak temperature (a). 
Example of one device with 35 mole % BPA crimped at loss modulus peak temperature (scale 
bar= 1 mm) (b). Images taken at 2.5× magnification. 
 
 
It is notable that during the constrained recovery tests, two out of the five 25 mole% BPA 
devices and four out of the five 35 mole% BPA devices developed cracks and subsequently 
broke.  Images of crack development at different temperature points during constrained 
recovery of 25 and 35 mole % BPA devices are shown in Figure 2.10. 
 
Bench-top thrombus removal 
Three 5 and 15 mole % BPA devices were subjected to thrombus removal experiments with 
flow.  In order to better simulate in vivo conditions, we chose an experimental flow rate of 57 
ml/min because this flow rate is equivalent to 113 ml/min in the MCA after dynamic 
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similarity via matching of the Reynolds number (Re).  This dynamically similar flowrate is 
within the range of flow rates recorded in the MCA, a common site for thrombotic occlusion 
in the neurovasculature [71]. 
 
 
 
                                                           
Figure 2.8. Force measurements of devices crimped at tan delta peak temperature (a). One 35 
mole % BPA device crimped at tan delta peak temperature (scale bar= 1 mm) (b). Images taken 
at 2.5× magnification. White arrow points at failure site.  
 
 
Because the 25 and 35 mole % BPA devices developed cracks during recovery under 
constrained conditions, they were not considered for the thrombus removal experiments.  
Images of the thrombectomy experiments for a 15 mole % BPA device and a diagram of the 
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silicone vascular model that was used in the experiments are provided in Figure 2.11.  To 
demonstrate that the crimped devices were able to maintain their crimped geometries under 
physiological conditions, they were first immersed in 37  C water and positioned past a 
bovine thrombus in the silicone vessel model, as pictured in Figure 2.11(a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9. Recovery stress of devices during constrained recovery.  Increasing the amount of 
crosslinker results in an increase in the recovery stress measured under constrained conditions. 
 
 
 
 37 
 
 
 
Figure 2.10. Crack development in devices with 25 and 35 mole % BPA during constrained 
recovery test at different temperature points. 
 
 
After holding at 37  C to demonstrate shape fixity for 4-5 min, the water temperature was 
elevated to ~Tg + 15  C (max recorded temperature: 77  C) over the course of 45 s by injecting 
water near boiling temperature to the flow system.  The effect of increasing crosslink density 
on the device thrombus removal success is clearly demonstrated: 0/3 of the 5 mole % BPA 
devices resulted in a successful thrombus removal, while 2/3 of the 15 mole % BPA devices 
successfully removed the thrombus (i.e., the devices were able to move the thrombus from its 
origin at the bifurcation pictured in Figure 2.11(b) to the catheter at the end of the model 
vasculature, pictured in Figure 2.11(e)). 
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Figure 2.11. Actuation and thrombus removal with 15 mole % BPA device. Q: experimental 
flow rate.  After actuation (panel A) the device exerts enough recovery force to deform the walls 
of the silicone vessel  model as seen in panel B.  The device is able to hold the thrombus during 
removal as shown in panels C-E. 
 
 
Discussion 
The motivation of this study is the need for an SMP-based thrombectomy device that is 
capable of exhibiting sufficient recovery stress to reduce the likelihood of thrombus 
dislodgement during thrombectomy, while also being able to undergo sufficient deformation 
for catheter delivery.  While there are commercially available devices for thrombus removal, 
the potential complications that occur can be reduced by utilizing an SMP-based 
thrombectomy device [2, 51-53].  
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Our group has previously investigated SMP-based thrombectomy devices for thrombus 
removal, and one important finding during preliminary animal studies is that the recovery 
stress of an SMP-thrombectomy device is key to ensure thrombus entrapment and successful 
removal [62].  The devices tested in the bench-top thrombotic stroke model in this study 
consist of 5 and 15 mole % BPA crosslinker.  The average recovery stress of the latter is 
roughly one order of magnitude higher than that of the former.  This positive correlation 
between crosslink density and recovery stress in SMPs has been reported in numerous 
previous studies [56, 66, 67].  In an ideal rubber, elastic modulus is inversely proportional to 
the average molecular weight between crosslinks, so a more highly crosslinked rubber will 
exhibit greater stiffness than a more lightly crosslinked one [65].  Therefore, more energy is 
required to achieve a specific deformation in a more highly crosslinked rubber than in a more 
lightly crosslinked rubber.  Since the energy required to achieve these deformations is 
metastably stored when thermally actuated SMPs are strained and then cooled below their 
thermal transition regions, the force exerted by an SMP during recovery is consequently 
higher for a more highly crosslinked SMP [56, 65-67, 73].  None of the 5 mole % BPA 
devices (0/3) exert enough recovery stress to hold the thrombus in our bench-top thrombotic 
stroke model, while 2/3 of the 15 mole % BPA devices do retain the thrombus as it is being 
removed. 
 
The goal of varying crosslink density is to increase device recovery stress for improved 
thrombus hold.  However, increases in crosslink density also have a negative effect on device 
mechanical integrity: the majority of the 25 and 35 mole % BPA devices do not sustain the 
constrained recovery experiments.  The temperature at which the devices are crimped also 
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plays an important role in device integrity.  The strain-to-failure data in Figure 2.6 shows that 
the stress required to achieve specific deformations decreases with increasing temperature for 
all compositions.  Thus, it is expected that the forces required for crimping at higher 
temperatures (tan delta peak temperatures) are lower than those required for crimping at 
lower temperatures (loss modulus peak temperatures).  Also, significant failure rates 
occurred during crimping at tan delta peak temperatures, while no failures occurred during 
crimping at loss modulus peak temperatures.  This trend in failure during crimping was most 
likely observed because the samples are in higher toughness states at loss modulus peak than 
at tan delta peak temperatures (see Table 2.2).  As expected, failure rates are higher in 
devices with higher crosslink densities.  In all cases, failures originate at the base of the 
devices.  The devices that result in most failures have one characteristic in common: their 
strain capacities are significantly reduced (see strain-to-failure values at tan delta peak 
temperatures for 25 and 35 mole % BPA devices in Table 2.2).  Therefore, the high localized 
strains at the base of the devices in conjunction with material limitations and possible 
machining defects, most likely cause crack initiations that then lead to device failures.  
 
For the devices that are successfully crimped, the recovery stress under constrained 
conditions increases with increasing crosslink density.  Nonetheless, some of the devices 
with 25 and 35 mole % BPA, which have rubbery moduli greater than 10 MPa (see Table 
2.1), fail during constrained recovery.  In a similar manner to the findings in this study, 
Safranski et al. reported that for acrylic SMPs with rubbery moduli greater than 10 MPa, the 
crosslinking dominates the large strain mechanical properties of the network and a relatively 
brittle response is observed [69].  This pronounced brittle response in addition to possible 
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machining defects may be the reason for failures in the devices with higher crosslink 
densities during constrained recovery. 
 
Full constrained recovery experimentation represents a worst-case condition, but it is of great 
importance for a device such as the SMP flower-shaped thrombectomy device in this study.  
The pressure elastic modulus of the common carotid artery, for example, is reported to be on 
the order of 55 kPa for healthy patients [74].  However, as patients get older and arteries 
become more diseased, this value has shown to increase to about 165 kPa [75].  Simply 
testing an actuating thrombectomy device in a silicone vessel model alone and neglecting to 
perform constrained recovery experiments could result in device failures such as the ones 
observed during the constrained recovery experiments in this study to remain unnoticed 
because a silicone vessel model could be more compliant than a diseased artery.  Thus, 
constrained recovery analysis should be performed a priori to avoid fatal complications that 
would probably only come into play in a more realistic environment, such as a diseased 
artery in a stroke patient. 
 
Conclusion 
In this work we have reported an acrylic SMP system with glass transitions above body 
temperature in the range of 65 to 75  C with tailorable recovery stresses that were controlled 
by varying crosslink density.  The increase in recovery stress that came with increasing 
crosslink density also resulted in higher propensities for device failure.  Similarly, crimping 
temperature significantly influenced device failure: crimping at theoretical maximum 
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toughness state, loss modulus peak temperature, required a higher force, but minimized 
device failure, in comparison with crimping at tan delta peak temperature.  Devices with 
rubbery moduli greater than 10 MPa that were successfully crimped, failed upon constrained 
recovery testing.  Consequently, an optimal crosslink density for the SMP system reported in 
this study—one that both enables sufficient recovery stress for successful thrombus removal 
but also allows for sufficient device mechanical integrity—appears to be one that results in a 
rubbery modulus between that of the 15 mole % BPA sample (i.e., 6.0 MPa) and 10.0 MPa. 
 
Our results demonstrate that SMP materials with the highest rubbery moduli are not 
necessarily the best for applications requiring large deformations.  From the four different 
material compositions evaluated, devices with 15 mole % BPA gave the most favorable 
outcome.  They exhibited average maximum recovery stresses approximately 1 order of 
magnitude greater than those of the 5 mole % BPA devices and were also capable of 
undergoing the deformations necessary for device crimping.  The development of the tunable 
acrylic SMP system reported in the study ultimately enabled the fabrication of a 
thrombectomy device that is shorter than commercially available devices, possesses enough 
recovery force to remove a thrombus, and does not fail during constrained recovery. 
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CHAPTER III  
SMP-SMA THROMBECTOMY DEVICE 
In the previous chapter, a materials engineering solution to a significant clinical problem that 
has affected and continues to affect thousands of patients worldwide was presented.  Flower-
shaped thrombectomy devices were fabricated from a system of crosslinked acrylic SMPs to 
enhance the recovery stress of the devices for better thrombus hold during removal.  The 
results showed that devices with rubbery moduli between 6.0 and 10.0 MPa exhibited 
sufficient recovery stress for thrombus removal, and also possessed the necessary strain 
capacity for catheter delivery.  However, a major flaw that was encountered was the potential 
difficulty in centering the device with respect to the vessel lumen during actuation, as 
illustrated in Figure 3.1.  Poor device centering could result in gaps between the device and 
the vessel lumen post-actuation that increase the potential of thrombus dislodgement, 
regardless of the ability of the device to recover its primary shape.  This problem, which is 
related to the device geometry, prompts the need to re-evaluate the design of the 
thrombectomy device. 
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Figure 3.1. Flower-shaped thrombectomy device off-centered after actuation. Device was 
painted with a black marker for better visualization. 
 
 
Introduction 
One of the greatest advantages of the new commercially available technology in 
thrombectomy, called stent retriever technology, is that undeployed stents have a small 
enough undeployed outer diameter that enables them to be delivered through the thrombus.  
The general procedure for deployment is to position the self-expandable nitinol stent such 
that the thrombus is centered within their length.   Stents act as a temporary bypass and 
enable the rapid restoration of blood flow [76].  In addition, they are designed to ensnare the 
thrombus in their struts for removal.  Examples of these devices include the Revive
TM
 SE 
(Codman and Shurtleff, USA), the Aperio®  (Acandis, Germany) and the FDA-approved 
Solitaire
TM
 FR (ev3, USA) and Trevo® (Stryker, USA) [77].  Although stent retrievers have 
proven to outperform the Merci Retriever® (e.g., primary effectiveness endpoint success rate 
of 60.7% and 87.3% for the Solitaire
TM
 RF and Trevo® respectively versus 58% for the 
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Merci Retriever®), in some instances their use is severely limited [78, 79].  One of the 
biggest drawbacks is that their length, which is usually 20-30 mm, significantly reduces their 
post-deployment maneuverability in tortuous vessels such as the MCA.  Maneuverability is 
particularly difficult in atherosclerotic patients, whose calcified lesions and hard thrombi tend 
to catch on the struts of the stent often resulting in the inability to retrieve the device [76]. 
 
Nitinol is limited by maximum strains on the order of 10%, thereby significantly reducing the 
volume changing capabilities of nitinol-based thrombectomy devices, which is probably one 
of the primary reasons why their length cannot be reduced further.  In the case of the Merci 
Retriever®, 50 mm of wire are required to achieve 5 loops of the corkscrew shape with 
diameters between 2.7 and 1.1 mm [80].  The stents are shorter than the Merci Retriever®, 
but still long enough to cause problems upon thrombus removal [76].  Taking these facts into 
account, as well as the results that were discussed in Chapter II, a new set of design 
requirements is needed. 
 
Design requirements 
The approach that was taken in the design of the new thrombectomy device is based on the 
waterfall design control model implemented by the FDA.  The first step was the evaluation of 
the design requirements.  The criteria for the design requirements were based on the user 
needs, which got translated into design inputs.  Once a prototype was fabricated, bench-top 
tests were performed to verify that the design requirements were met.  Finally, validation of 
the design requirements was sought through the use of an animal model. 
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From the information in the literature, the limitations of the FDA-approved treatments of 
acute ischemic stroke were identified.  Among these limitations are the narrow treatment 
time window for tPA, arterial perforation and spasm, thrombus fragmentation and distal 
migration, limited post-deployment device flexibility, and restricted placement caused by the 
length of the devices that is required to be advanced beyond the thrombus [2, 7, 14, 42,53, 
76, 81-83].  Based on these complications, the user needs were defined as a thrombectomy 
device that can: 
1. increase the treatment time window; 
2. enhance thrombus hold; 
3. prevent distal migration of thrombus fragments; 
4. exhibit better post-deployment flexibility; and 
5.  require a shorter deployment length.  
 
The design of a distal device (i.e., the entire device is deployed distal to the thrombus) with 
deployment length shorter than commercial devices was employed.  Implementing such a 
design required that the outer diameter of the undeployed device be as small as possible to 
enable delivery through the thrombus.  Therefore, a material able to achieve high volume 
expansion rates was needed, such that it could be small enough for through-thrombus 
delivery, be large enough to conform to the vessel lumen for thrombus removal, and offer 
sufficient rigidness for thrombus hold, while keeping the length of the device as short as 
possible.  In order to supply these various material requirements, a hybrid device design that 
combined the use of SMP foam and nitinol was selected.  The device concept is shown in 
Figure 3.2 and it consisted of the delivery of crimped SMP foam and a flower-shaped nitinol 
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portion past the thrombus, followed by the actuation of the SMP foam and subsequent 
removal of the thrombus.  SMP foam was proposed as a major component of the 
thrombectomy device because it has density values less than 0.03 g/cm
3
, which enables a 
volume expansion rate of over 20× [55].  Additionally, preliminary animal studies have 
shown that SMP foams have good biocompatibility [84].  Nitinol was selected as the second 
component of the thrombectomy device because it is capable of exhibiting shape memory, it 
has superior yield strains than comparable alloys such as stainless steel 316 L, and its 
compliance can be modified through the use of heat treatments [59, 85].  Furthermore, it has 
been widely used in FDA-approved medical devices, including the two most recently FDA-
cleared thrombectomy devices [59].  The nitinol portion of the device was intended to 
compress the free-moving SMP foam against the thrombus to prevent the slippage of the 
SMP foam out of the device assembly.  Its pre-shaped four-strut flower geometry (hence the 
name shape memory nitinol flower (SNF)) when unloaded provides the struts with a finite 
radius of curvature and reduced tension that allows the struts to buckle more easily providing 
a larger diameter for the SNF to compress the SMP foam (see Appendix A for previous 
design iterations).  From preliminary experiments it was observed that the axial compression 
applied to the SMP foam during thrombus removal resulted in favorable radial expansion.  
From this data we hypothesized that this diameter expansion would allow the SMP foam to 
better conform to the uneven lumen of the occluded vessel during thrombectomy, thus 
preventing device-vessel gaps that could result in the distal migration of smaller thrombi.  
The design inputs for the SMP foam-nitinol thrombectomy device are listed in Table 3.1. 
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Figure 3.2. Design concept of new hybrid thrombectomy device.  Upon distal delivery, the SMP 
foam actuates to its primary shape and the SNF supports the SMP foam as it gets compressed 
against the thrombus during removal. 
 
 
Table 3.1. Summarized design inputs for hybrid thrombectomy device. 
Parameter Target range Acceptable value 
Length of device 6-8 mm <15 mm 
Diameter of crimped foam 0.6-0.8 mm 1 mm 
Diameter of undeployed nitinol flower <0.8 mm 1 mm 
Diameter of actuated foam > diameter of target 
vessel 
= diameter of target 
vessel 
Device-catheter friction force (6 F 
catheter) [86] 
 < 0.3 N 0.5 N 
Device working time Unlimited for 
deployment, < 2 min for 
retrieval 
10 min for 
deployment,  
< 5 min for retrieval 
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Design selection 
The selection of the final design of the hybrid thrombectomy device entailed preliminary 
experiments for the selection of the SMP foam type, particularly regarding the shape of the 
SMP foam sample (i.e., cylindrical vs oval) and the average cell size.  The chemistry of the 
SMP foams can be found in [87].   
 
From preliminary axial compression tests in 37  C water, it was observed that the shape of the 
SMP foam affects the amount of radial expansion.  As shown in Figure 3.3, cylindrical SMP 
foam samples exhibit greater diameter expansion rates as a function of axial compression, 
compared to oval samples.  Thus, cylindrical samples were selected as the shape of the SMP 
foam component of the thrombectomy device.   
 
To determine the appropriate range of SMP foam cell size for this application, SMP foams 
with three different cell sizes were fabricated by varying the viscosity of the pre-polymer 
mix.  The resulting SMP foams are pictured in Figure 3.4, and the average cell size, density 
and Tg measured by differential scanning calorimetry (DSC) are listed in Table 3.2.  The 
SMP foams were labeled as F44, F68 and F110 to represent their average cell sizes, which 
were 0.44, 0.68 and 1.1 mm respectively.   
 
Cylindrical samples of each SMP foam type were cut using a biopsy punch (Sklar 
Instruments) with 6 mm diameter.  The length of all SMP foam samples was cut to 5 mm 
with a straight edge razor.  The shape recovery rate of the three types of SMP foams and the 
diameter expansion as a function of axial compression were tested in 37  C water.  For each 
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test, three samples of each SMP foam type were evaluated.  The shape recovery rate 
experiment consisted of submerging one sample of crimped SMP foam at a time in 37  C 
water and acquiring images with a photographic camera (Canon, Powershot SX 230 HS) 
every 10 seconds.  Three diameter measurements were made at every time point using 
ProGress Pro capture Software, which was calibrated for every image.  The axial 
compression experiments were performed in a similar manner, except that the foam was 
compressed to known percentages using a custom-machined acrylic apparatus.  This 
apparatus consisted of a rectangular acrylic container with a movable insert.  The insert was 
moved by the rotation of two screws towards one of the walls of the acrylic container.  The 
acrylic container and insert had a center hole through which a 0.25 mm diameter wire was 
fed.  The wire held the sample of SMP foam in place as the insert was moved to compress the 
sample axially.  Images at compression percentages of 0, 15, 30, 45, 60 and 75% were 
acquired utilizing the Canon camera, and three diameter measurements were taken at each 
compression level.  The shape recovery and diameter expansion as a function of axial 
compression in 37  C water for all three foam types are shown in Figures 3.5 and 3.6 
respectively. 
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Figure 3.3. Preliminary results of radial expansion of the SMP foam as a function of axial 
compression. A first-order least squares fit is applied to the data.  Cylindrical samples achieve a 
greater diameter increase as a result of axial compression compared to the oval samples. 
 
 
 
Figure 3.4. SMP foams considered in the selection of the final design of the hybrid 
thrombectomy device.  The average cell sizes are 0.44, 0.68 and 1.14 mm for foams F44, F68 
and F110 respectively. 
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Table 3.2. Properties of SMP foams. 
SMP foam label F44 F68 F110 
Average cell size (mm) 0.44 + 0.14 0.68 + 0.21 1.14 + 0.40 
Density (g/cm
3
) 0.026 0.027 0.028 
Tg ( C) 60 59 56 
 
 
 
Figure 3.5. Shape recovery in      ater of foams          and       n      A better shape 
recovery is observed for SMP foams with smaller cell size compared to SMP foams with larger 
cell size (e.g., F44 versus F110). 
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Figure 3.6. Diameter expansion in      ater of foams          and       n      Foam F44 
exhibits a greater diameter increase as a function of axial compression compared to foams F68 
and F110. 
 
 
From these preliminary experiments it was concluded that smaller average cell sizes (less 
than 0.44 mm) showed better shape recovery (i.e., 90% compared to < 60% within the first 
90 seconds of water at body temperature exposure) during passive actuation, and greater 
amount of diameter expansion as a function of axial compression (i.e., 12% versus < 2%) 
compared to SMP foams with average cell size greater than 0.68 mm.   
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Materials and methods 
Proof of concept 
SNF machining: The SNF was fabricated from nitinol tube with 0.4 mm outer diameter and 
0.3 mm inner diameter purchased from NDC.  Four 5 mm long straight struts were laser cut 
along the surface of the tube every 90  using an excimer laser with a rotary axis (RapidX, 
Resonetics) with the following settings: 248 nm wave length; demagnification of 29; mask 
size of 2 mm; power of 4 mJ; frequency of 100 Hz, and 100 pulses. These settings were 
selected because machining was achieved on average in only two passes with an amount of 
power and frequency rate that did not overburden the laser.  After the struts were laser cut, 
the piece was sliced from the rest of the nitinol tube utilizing the same laser settings, and its 
final length was 7 mm.  Then, the cut area was carefully sanded with 600 grit sand paper and 
cleaned with acetone.  To set the flower shape, the laser-cut nitinol tube was mounted on a 
custom-made aluminum fixture that allowed for a gradual and controlled compression of the 
SNF axially, resulting in the buckling of the struts.  The nitinol tube mounted on the fixture 
were then placed inside a furnace at 550  C for 7 minutes and subsequently quenched in water 
at room temperature. 
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Figure 3.7. Aluminum fixture for SNF shape setting.  The set screw on the right is utilized to 
move the center piece for the gradual and controlled compression of the SNF between two 
washers.  Once the desired deformation is achieved, the fixture is placed in a furnace at 550   C 
for 7 minutes. 
 
 
Bench-top thrombotic model: The SNF was adhered to the distal tip of a 1000 mm long 
nitinol wire with 0.25 mm diameter purchased from NDC, using medical grade UV curable 
epoxy (Epotek).  Proximal to the SNF was crimped a cylindrical sample of foam F44.  Three 
samples of foam F44 were cut with 6, 8 and 10 mm diameters and their length was kept at 5 
mm.  The prototypes were tested in the same thrombotic stroke model as described in 
Chapter II utilizing bovine thrombi prepared as previously described (see Figure 2.4). 
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Device fabrication 
Tungsten-doped SMP foam characterization: SMP foams doped with tungsten at a 
concentration of 4% by weight were utilized in the devices that were fabricated for the 
animal study.  Tungsten acts as an inert filler to make SMP foam visible under fluoroscopy, 
which is the standard imaging modality for clinical and pre-clinical endovascular procedures 
[84].  The average cell size, density and Tg of the doped SMP foam was 0.18 + 0.077 mm, 
0.70 + 0.0058 g/cm
3
 and 60  C, respectively.  Cylindrical samples of this SMP foam were cut 
using the 6 mm diameter Sklar biopsy punch.  The length of all SMP foam samples was cut 
to ~5 mm with a straight edge razor.  The shape recovery rate and the diameter expansion as 
a function of axial compression of the SMP foam were tested in 37  C water (n=3).  The shape 
recovery rate experiment consisted of submerging one sample of crimped SMP foam at a 
time in 37  C water and acquiring images with the Canon Powershot camera every 10 
seconds.  Three diameter measurements were made at every time point using the ProGres Pro 
capture software, which was calibrated for every image.  The axial compression experiments 
were performed using the Instron dual column tensile tester with a 50 N load cell (with 
resolution of 0.00025 N).  For these experiments, the crosshead was manually controlled 
utilizing the Instron’s fine position thumb  heel, to SMP foam compression levels of 0, 15, 
30, 45, 60, and 75%, and the load was recorded by hand.  Images were acquired using the 
Canon Powershot camera, and three diameter measurements were made at each compression 
level using the ProGres Pro software.  To ensure that the SMP foams were in rubbery state 
during each experiment, they were kept saturated with water at ~70  C. 
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Guidewire fabrication and device assembly:  The same nitinol tube used for the SNFs 
(length=1220 m) was utilized in the guidewire construction.  Braided nitinol wire (Assahi 
Intecc, actone flat) (length= 330 mm) with 0.31 mm outer diameter and 0.16 mm inner 
diameter was inserted in the distal end of the nitinol tube, and a 1064 nm YAG laser welder 
(i990, LaserStar) was used to weld both components.  The final device was assembled by 
welding the pre-shaped SNF at the distal tip of the actone flat utilizing the LaserStar laser 
welder, followed by the crimping of a sample (diameter ~6 mm, length ~5 mm) of tungsten-
doped SMP foam proximal to the SNF as shown in Figure 3.8(A).   
 
Device delivery system: The SMP foams that were utilized for this thrombectomy device are 
hydrophilic and get plasticized when exposed to moisture [88].  Plasticization is caused by 
hydrogen bonding bet een the  MP foam’s carbonyl groups and the  ater molecules   As a 
result, the gaps between the polymer chains increase and therefore have higher mobility 
reducing the Tg of the SMP foam [55].  Therefore, the catheter delivery of the thrombectomy 
device is challenging because there is a risk of premature SMP foam actuation prior to 
deployment.  To solve this problem, a delivery system that constrained the SMP foam during 
catheter delivery and achieved deployment by means of a pusher and a hex cap screw, was 
designed and implemented as shown in Figure 3.8(B).  
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Figure 3.8. Guidewire assembly (A) showing a picture of an actual device acquired at 1.25× 
magnification (scale bar= 5 mm), and delivery system construction showing a crimped device 
inside the PTFE tube (1.25× magnification, scale bar= 5 mm) (B).  The delivery system 
functions by means of a pusher that is activated by the rotation of a screw. 
 
 
The entire device assembly was inserted in an 18 AWG, lightweight wall, medical grade 
PTFE tube purchased from Zeus with the SMP foam positioned at the distal tip of the PTFE 
tube.  Eight holes were punctured on the PTFE tube around the location of the SMP foam 
using a 23 gauge needle to aid in the flushing of water to remove air from the tube prior to 
being delivered through the catheter.  The PTFE tube was attached to an 18 gauge needle, 
whose length was cut to 8 mm, and whose distal tip was dulled using a dremmel.   
 
An acrylic holder was fabricated utilizing the Roland CNC and it served to support a 
cylindrical acrylic insert that contained a luer lock on one end, and a 14 mm long threaded 
hole on the other end.  These two features were connected by a 1.3 mm hole.  The modified 
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18 gauge needle served as the attachment between the PTFE tube and the acrylic insert by 
means of the luer lock, allowing the guidewire to be advanced through both parts.  A nitinol 
tube (outer diameter 0.58 mm, inner diameter 0.51 mm), with an outer diameter small enough 
to fit through the PTFE tube and 18 gauge needle, and with an inner diameter large enough to 
fit the guidewire in its lumen, was utilized as the pusher.  It was inserted through the 
proximal end of the guidewire up to the location of the crimped SMP foam.  The length of 
the pusher was cut such that when a hex cap screw, which had a 0.46 mm diameter hole 
through the center (small enough to fit the guidewire but not the pusher), was screwed to the 
end of the threaded 14 mm hole, the distal end of the pusher was flush with the distal end of 
the PTFE tube, thereby pushing the SMP foam out.  A female luer lock was adhered with a 
cyanoacrylate-based glue (360, Loctite) to the 18 gauge needle holding the PTFE tube.  Its 
purpose was to allow the proximal end of the catheter to be locked to the entire delivery 
system, so that during thrombus removal, all components could be retrieved as a single unit.  
Thus, it was necessary that the length of the PTFE tube was sized according to the length of 
the catheter.  A 3-way stop cock was glued to the cap of the hex screw, and a Touhy borst 
adaptor was used to make the proximal end of the delivery system water tight to enable the 
flushing of air from the PTFE tube.       
 
Bench-top testing 
Weld tensile strength: It has been shown that welding nitinol results in joints with decreased 
strength compared to stainless steel welded joints, mainly due to the oxide layer in the 
surface of nitinol components [89].  Furthermore, the selection of the welding parameters has 
an effect on the mechanical performance of the joints [90].  In order to determine the 
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LaserStar welding parameters utilized in both weld types, the three different settings listed in 
Table 3.3 were evaluated in samples separately prepared for tensile testing (n=3).  The center 
welds were intended for the nitinol tube-actone flat joint, and the end weld for the SNF-
actone flat weld.  The goal was to find the setting that resulted in the highest possible fracture 
load. To achieve this goal, welded samples were extended to failure at an extension rate of 75 
mm/min (the same extension rate utilized in the bench-top thrombectomy) using the Instron 
Tensile tester with the 50 N load cell.  Data were recorded at 1 Hz through BlueHill 3 
software. 
 
 
Table 3.3. Laser welding parameters for the assembly of nitinol components. 
Type of 
weld 
Voltage (V) 
Pulse 
duration (ms) 
Frequency 
(Hz) 
Beam 
diameter 
(mm) 
Pulse 
shape 
Center edge 157 0.9 2 0.55-0.8 Square 
Center tube 155 0.9 2 0.55 Square 
End 155 0.9 2 0.55 Square 
 
 
Device-catheter friction: The friction forces resulting from pushing and pulling the 
assembled device through both a 5 and 6 F catheters (Cordis, 0.056” and      ” inner 
diameter respectively) were measured.  The catheter was mounted onto the Instron tensile 
tester as pictured in Figure 3.9 and the assembled device was displaced through it at a rate of 
100 mm/min in extension and compression modes.  Water was injected to the catheter prior 
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to testing, and the friction forces between the two components were recorded at 1 Hz with the 
50 N load cell (resolution 0.00025 N, lower limit 0.05 N) using BlueHill 3 software.  
 
Load to push actuating SMP foam: The force required to push a crimped sample of 
tungsten-doped, actuating SMP foam out of the PTFE tube was also measured.  Samples with 
the same dimensions as those used in the device assembly were crimped over a ~3 cm long 
piece of actone flat, and then were inserted into the PTFE tube.  They were then submerged 
in a water bath at approximately 70  C while the pusher, which was held by the manual grip 
of the Instron tensile tester, was displaced in compression at 15 mm/min until the foam was 
pushed out (n=3). The load was recorded with a 50 N load cell (resolution 0.00025 N, lower 
limit 0.05 N) at 1 Hz using BlueHill 3 software. 
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Figure 3.9. Experimental setup for device-catheter friction force measurements.  The device 
inside the delivery system is inserted in the catheter such that both distal ends are flush with 
one another.  The device is displaced by the movement of the crosshead in extension and 
compression for 30 mm when using a 5 F catheter, and 300 mm when using a 6 F catheter. 
 
 
PTFE tube-needle attachment strength: To determine if the strength of the attachment 
between the PTFE tube and the 18 gauge needle was enough to sustain the load required to 
push the actuating SMP foam out of the PTFE tube, the load required to pull apart said 
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attachment was tested.  An extension rate roughly five times higher (i.e., 75 mm/min) than 
the extension rate expected for pushing the actuating SMP foam out of the PTFE tube was 
used to simulate a worst case condition.  Three samples were tested using the Instron tensile 
tester with the 50 N load cell.  Data were acquired at 1 Hz via BlueHill 3 software.  
 
Thrombus compressive stress: The same thrombus preparation protocol and thrombotic 
stroke model were used as described in Chapter II to test the feasibility of the hybrid 
thrombectomy device.  The compressive mechanical properties of the resulting thrombi were 
measured using the 50 N load cell at a compression rate of 1 mm/min until reaching a 
maximum load of 15 N for three samples cut utilizing 10 mm diameter biopsy punches.   
 
Animal testing 
The pilot animal procedure was approved by the Texas A&M University Institutional Animal 
Care and Use Committee (IACUC) and was conducted according to its policies.  An incision 
was made in the neck of a 25 kg Yorkshire pig, and the left carotid artery was accessed.  A 
10 F sheath was inserted utilizing a dilator, which was advanced through the distal aorta 
attempting to reach one of the femoral arteries.  A piece of bovine thrombus, aged for 1.5 
weeks, was cut using a 10 mm biopsy punch and was injected through the 10 F sheath 
utilizing saline solution at room temperature.  The thrombus got lodged in the distal femoral 
artery, after which it elongated to roughly 50 mm.  The thrombus was allowed to mature in 
this location for 15 minutes and contrast was injected subsequently to confirm the occlusion.  
 onsequently, a     5” guide ire  as ad anced through the occlusion and a 5 F catheter 
was advanced over the guidewire such that its tip was placed distal to the thrombus.  The 
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device was delivered through the 5 F catheter, and after roughly 1 minute of incubation at 
body temperature, the tungsten-doped SMP foam was deployed.  The catheter and device 
were placed such that the thrombus was entrapped between the two, and their position was 
locked utilizing the Touhy borst adaptor on the hex cap screw.  The entire device assembly 
was pulled towards the tip of the 10 F sheath, allowing for the restoration of blood flow.  
This procedure was repeated using 4 more devices. 
 
Results 
With this new design concept, thrombectomy devices with a deployment length of only 12 
mm, and a crimped diameter of 1 mm were fabricated.  Our initial goal was to fabricate a 
device that could be delivered through a 6 F catheter; however, this device and delivery 
system were small enough to fit through a 5 F catheter. 
  
Proof of concept 
All of the experiments (3/3) that were performed with the 1, 1.5 and 2× sized SMP foams 
were successful, i.e., the thrombus did not get dislodged through the bifurcation vessels.  Still 
images of the thrombus extraction at different locations in the vessel model are shown in 
Figure 3.10 for the 1 and 2× cases.  On the same figure is a graph of the load recorded during 
each thrombus removal trial.  There was not a significant difference in the force recorded for 
the devices with 1 and 1.5× sized SMP foams; the maximum recorded load was 0.7 N.  In 
contrast, the maximum recorded load for the devices made with 2× sized SMP foams was 
1.85 N.   
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From the still images in Figure 3.10 it can be observed that the SMP foam tends to adhere to 
the thrombus, which aids in its retention.  In the case of the 1× sized SMP foam, panel B 
depicts that the diameter of the SMP foam is too small to come in full contact with the 
thrombus.  Thus, more than half of the thrombus body had an open path to flow into the 
second segment artery of the vessel model.  However, the thrombus stayed attached to the 
SMP foam during the entire procedure.  In order to further investigate this observation, one 
sample of SMP foam was placed on a thrombus that had been allowed to incubate at room 
temperature overnight.  Bovine blood at 37  C was added to the vial, and after four minutes 
the SMP foam and thrombus were taken out of the vial for inspection.  Figure 3.11 pictures 
the SMP foam-thrombus interface while being held from the SMP foam only by a pair of 
tweezers.  The adhesion between the SMP foam and the thrombus is evident.   
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Figure 3.10. Bench-top thrombus removal results showing still images of thrombus removal 
procedure at different locations of the vessel model for devices with 1 and 2× sized SMP foams.  
Recorded load during the experiment for all devices tested (the diameter of occluded artery, 
second segment and parent artery are 5, 7 and 8 mm respectively). 
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Figure 3.11. SMP foam adhesion to bovine thrombus after being incubated in a vial filled with 
bovine blood for 4 minutes.  By holding only the SMP foam with tweezers it is evident that the 
thrombus had adhered to the SMP foam during the incubation. 
 
 
The shape recovery and diameter expansion as a function of axial compression of the 
tungsten-doped SMP foam is shown in Figures 3.12 and 3.13 respectively.  After being 
exposed to water at 37  C for 90 seconds, the tungsten-doped SMP foam recovers 95% of its 
original shape.  This SMP foam, while in rubbery state, only requires 0.13 N to achieve 
~75% axial compression, resulting in roughly 45% radial deformation. 
 
 
 68 
 
 
 
Figure 3.12. Shape recovery of tungsten-doped (4% by weight concentration) SMP foams in 
37  C water.  A maximum shape recovery of roughly 95% is observed. 
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Figure 3.13. Diameter expansion as a result of axial compression and resulting compression 
load for tungsten-doped (concentration of 4% by weight) SMP foams while in rubbery state.  
An average axial compression load of roughly 0.12 N is required for the tungsten-doped SMP 
foam to achieve a diameter expansion of approximately 45%. 
 
 
Bench-top testing 
Weld tensile strength: Scanning electron microscopy (SEM) images of all three weld types 
are shown in Figure 3.14(A-C).  The center edge weld, shown in Figure 3.14(A) fractured at 
an average load of 1.8 + 0.97 N; in contrast, the center tube weld fractured at an average load 
of 25 + 6.0 N.  The SEM data shown in Figure 3.14(B) depicts how the center tube weld 
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made the nitinol tube conform to the actone in its lumen, almost acting like a shrink wrap 
without the need of exposing the actone to the laser beam.  The end weld resulted in a 
smooth melt between the two components as shown in Figure 3.14(C).  Its failure load was 
14 + 2.3 N.  Because of the improved tensile strength of the last two welds compared to the 
first type, the center tube weld was implemented in the guidewire portion of the device, and 
the end weld for attaching the SNF to the guidewire.   
  
 
 
Figure 3.14. Laser welding of nitinol tube and actone flat braided wire at the edge of the tube 
(center edge weld) (A), on the tube only without contacting the actone flat (center tube weld) (B) 
and at the end of the flush nitinol tube-actone flat interface (end weld) (C). 
 
 
Device-catheter friction: The friction forces between the assembled device inside the PTFE 
tube of the delivery system and a 5 F catheter over a 30 mm distance are plotted in Figure 
3.15.  The maximum average loads recorded during the pull and push cycles were 1.28 N and 
1.48 N respectively.  The pushing action required an overall higher amount of force 
compared to the pulling action.  
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Figure 3.15.  Load required to pull and push the assembled device through a 5 F catheter.  The 
loads recorded during the push cycles are overall higher than the loads recorded during the 
pull cycles. 
 
 
The friction forces resulting from pulling and pushing the assembled device inside the PTFE 
tube over a 300 mm distance through a 6 F catheter are depicted in Figure 3.16.  The 
maximum average load recorded during the pull cycle was 0.21 N and that during the push 
cycle was 0.37 N.  The overall pushing force was higher than the pulling load.   
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Figure 3.16. Load required to pull and push the assembled device through a 6 F catheter. As 
shown in the previous figure, the loads recorded during the push cycles are overall higher than 
the loads recorded during the pull cycles. 
 
 
Load to push actuating SMP foam and to pull apart PTFE tube-needle attachment: 
Figure 3.17 shows an example of the experimental procedure to measure the load required to 
push a sample of tungsten-doped SMP foam while it is actuating in hot water (6 mm 
diameter, 5 mm length) out of the PTFE tube.  Figure 3.18 shows the average force required 
to push three SMP foams out the PTFE tube during actuation.  The load ramped from 0 to a 
maximum of 3.2 N within the first 2 mm of compression.  It then gradually decreased back to 
approximately 0 N after the whole SMP foam sample was completely pushed out of the 
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PTFE tube.  This peak force was almost four times smaller than the force required to pull 
apart the PTFE tube-needle attachment, which was 11.9 + 2.52 N. 
 
 
 
Figure 3.17.   ample of one tun sten-doped actuatin      foam sample push e periment in 
 ater at         Experiment was conducted by attaching the nitinol pusher to the crosshead of 
the Instron tensile tester, and displacing it at a rate of 15 mm/min in compression mode. 
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Figure 3.18. Average force required to push three actuating tungsten-doped SMP foam samples 
(6 mm diameter, 5 mm length) through the 18 AWG lightweight wall, medical grade PTFE 
tube.  The strength of the PTFE tube-syringe attachment is 11.9 + 2.52 N. 
 
 
Thrombus compressive stress:  Bovine thrombi containing 1 g of barium sulphate and 25 
IU of bovine thrombin per 10 ml of bovine blood, required 83.3 + 0.762 % strain to achieve a 
compressive stress of 0.19 MPa.  These values are within the range of published stress-strain 
data for human red thrombi [91].   
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Animal results 
During the animal study, only the first device was able to successfully remove the blood clot 
from its occluded location, as seen in Figure 6. After confirming occlusion (Figure 3.19(A-
B)), the device was successfully deployed utilizing the hex cap screw pusher method, and 
approximately after 60 seconds, the tungsten-doped SMP foam was actuated (arrow in Figure 
3.19(C)). As pictured in Figure 3.19(D-F), the clot extractor was able to move a ~50 mm 
long blood clot from the occluded location, to the tip of the 10 F sheath. Given that this 
sheath was too large for the vessels of this pig, we decided to keep in in place to avoid vessel 
dissection. Thus, the same procedure was repeated in the same vessel with a second device 
utilizing the same nitinol pusher and delivery mechanism. After the hex cap screw was fully 
rotated, the SMP foam was still inside the PTFE tube. This device was removed, and a new 
one was delivered through the catheter. This instance, a new nitinol pusher was used, and the 
SMP foam was successfully deployed out of the PTFE tube. As the device was pulled in an 
attempt to remove the blood clot, the device slid through the clot, failing to move it. Two 
more devices were delivered to remove the same clot; however, the devices slid through the 
clot as in the previous time. 
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Figure 3.19. Control angiogram prior to injecting the clot (A) and after the clot was injected 
followed by contrast (B) (white arrows point at blood clots). Deployed device distal to the clot 
(C) (arrow points at SNF and actuated SMP foam), and device-clot interface during removal 
(D-F). 
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Discussion 
A hybrid thrombectomy device made with SMP foam and nitinol has been proposed as an 
alternative design to the new wave of commercially available thrombectomy devices, stent 
retrievers.  By combining the benefits of both types of shape memory materials, a 
thrombectomy device that is shorter and has a lower modulus in vessel contacting surfaces 
was fabricated.  This reduction in length helps mitigate common complications that are 
associated with the use of thrombectomy stents that often result in treatment failure.  The 
resulting hybrid thrombectomy device was able to move a ~50 mm long clot from its 
occlusion site, to the delivery sheath, revascularizing the femoral artery of a pig.   
 
In a study by Castaño et al. (2010), the Solitaire stent failed to achieve restoration of blood 
flow in all the cases in which the blood clot was longer than the stent [92].  Conversely in our 
animal study, our proposed thrombectomy device was able to hold a thrombus that was 
almost 5 times its length, and almost twice as long as any of the stent retrievers.  While this 
positive result was only observed in the first device tested, the fact that the clot was not 
successfully removed in the following cases is not necessarily attributable to device failure.  
One possible explanation for the missed clot removals could be that the occluded vessel got 
dilated.  From the angiogram images it was observed that the diameter of the occluded vessel 
got on average 35% larger in the subsequent clot extraction attempts, requiring the use of a 
device with a larger SMP foam sample that was not available.  This reason, exacerbated by 
the fact that the multiple catheter passes through the clot might have created a channel that 
made it easier for the actuated SMP foam to slip through it, was a major role player in the 
outcome of the devices that were tested last. 
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The bulk of this work was devoted to verifying that the design outputs met the design inputs.  
Because this device has gone through multiple design iterations as shown in Appendix A, the 
number of design requirements has had to broaden to accommodate the changes.  Thus, the 
final design requirements were based on user needs, information about predicate devices, and 
information in the literature; and are applicable to the design presented in this chapter.  With 
this information, performance specifications and verification tests were outlined as listed in 
Table 3.4.  The most important parameters for the SMP foam were crimped diameter, shape 
recovery and radial deformation as a function of axial compression.  The design requirements 
were within specification only for the SMP foam with the smallest average cell size (F44), 
and expectations were exceeded by the implementation of the tungsten-doped SMP foam, 
primarily because it had an even smaller average cell size.  The parameters of the nitinol 
backbone were also within specification, and in some cases, the results exceeded the 
expectations.  For example, the outer diameter of the non-actuated nitinol backbone was 0.4 
mm, which is 0.06 mm smaller than the proximal core wire diameter of its predicate device, 
Trevo® according to the Trevo Retriever 510(k) summary [79].  Additionally, the tensile 
data revealed that the center welds are a novel method of attaching nitinol braided wire 
(actone) to nitinol tube, as its fracture load was 14 times higher compared to the fracture load 
of the typical edge welding method.  For the delivery system, the tensile strength of the PTFE 
tube-needle attachment was also within specification, as it resisted a load that was 3.7× the 
load required to push actuating tungsten-doped SMP foam out of the PTFE tube.  Finally, the 
deployment length of the device was 3 mm below the maximum accepted value defined in 
the design inputs, showing a significant advantage over all predicate devices.  The force 
required to pull the devices through a 6 F catheter was also below the maximum accepted 
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value defined in the design inputs, and is comparable to the friction measured between a 0.47 
mm inner diameter microcatheter and 0.41 mm guidewire in a tortuous path [86].     
 
SMP foam adhesion to the thrombus was observed during the bench-top thrombectomy trials, 
and we believe this phenomenon is caused by the high surface area of the SMP foams that is 
in contact with the thrombus, compared to the surface area of contact between the thrombus 
and a nitinol-based device.  The ability to size the portion of the thrombectomy device that is 
in contact with the thrombus during removal according to the cross-sectional area of the 
occluded vessel is an advantage of this device compared to commercially available predicate 
thrombectomy devices because it helps in thrombus retention during removal.  Thrombus 
retention is often poor in commercially available devices, which is why thrombus 
dislodgement is found as a major drawback in mechanical thrombectomy in the literature [2, 
7].   
 
A major concern of the implementation of distal devices for the treatment of stroke is that, as 
the catheter is advanced through the thrombus, there is a high probability of small fragments 
getting cut off the thrombus and migrating distally.  We have observed this issue in our 
bench-top experiments; while in some cases the fragment adhered to the SMP foam, in others 
it got flushed distally with the flow of water.  Even though this problem is present in every 
distal device, using large catheters with high profiles (i.e., edges that do not transition 
smoothly) increases the probability of thrombus fragmentation as well as the size of the 
fragments.   
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Table 3.4. Performance specifications and verification tests for the SMA-SMP thrombectomy device. 
 
 
 
 
 
 
Device 
component 
Design 
requirement Units 
Target 
value 
Accepted 
range Criteria Method of verification Result 
SMP foam 
Crimped 
diameter (mm) 0.6 0.6-1 
Catheter 
delivery 
Verify that crimped SMP foam fits 
inside PTFE tube 
Passed 
for 6 mm 
diameter 
tungsten-
doped 
SMP 
foams 
Shape 
recovery (%) 95 80 
Full occluded 
vessel lumen 
conformation 
when actuated 
Allow SMP foam to passively actuate in 
37   C water and acquire images every10 
s.  Perform three diameter measurements 
at each time point utilizing ProGres 
Capture Pro software with proper 
calibration. Repeat with three samples. 
Passed 
for 
tungsten-
doped 
SMP 
foam 
Radial 
deformation 
as a function 
of axial 
compression (%) 30 10 
Ability to 
conform to 
vessel lumen 
for sections 
that are 
tapered out 
Compress the actuated SMP foam in 
37  C water and acquire images at every 
compression point.  Perform three 
diameter measurements at each time 
point utilizing ProGres Capture Pro 
software with proper calibration. Repeat 
with three samples.  
Passed 
for 
tungsten-
doped 
SMP 
foam 
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Table 3.4 Continued. 
 
Device 
component 
Design 
requirement Units 
Target 
value 
Accepted 
range Criteria Method of verification Result 
Nitinol 
backbone 
Outer 
diameter of 
non-
actuated 
SNF and 
guidewire (mm) 0.8 0.8-1 
Catheter 
delivery Measure with calibrated caliper Passed 
Diameter of 
actuated 
SNF (mm) 2.5 2.5-2.7  
Risk of vessel 
injury upon 
contact 
Acquire images and measure diameter 
with ProGres Capture Pro software with 
proper calibration Passed 
Fracture 
load of 
center weld (N) >10 8 
Maximize 
fracture load 
with respect to 
bench-top 
thrombus 
extraction load 
of 1.85 N 
Perform tensile test at same extension 
rate used for thrombus extraction 
experiment 
Passed for 
center 
tube weld 
Fracture 
load of end 
weld (N) >10 8 
Maximize 
fracture load 
with respect to 
bench-top 
thrombus 
extraction load 
of 1.85 N 
Perform tensile test at same extension 
rate used for thrombus extraction 
experiment Passed 
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Table 3.4 Continued. 
 
Device 
component 
Design 
requirement Units 
Target 
value 
Accepted 
range Criteria Method of verification Result 
Delivery 
system 
Tensile 
strength of 
PTFE tube-
syringe 
attachment (N) 12.8 6.4 
Maximize 
tensile 
strength of 
attachment 
with respect to 
load to push 
actuating SMP 
foam of 3.2 N 
Perform tensile test at extension rate 5 
times higher than rate used to push SMP 
foam out of the PTFE tube Passed 
Assembled 
device 
Deployment 
length of 
device (mm) 8 <15 
Comparison 
against 
commercially 
available 
devices, which 
require at least 
15 mm of 
deployment 
length  
Acquire image and measure with 
ProGres Capture Pro software with 
proper calibration Passed 
Pull and 
push force 
required for 
advancemen
t through 6 
F catheter in 
a tortuous 
path (N) 0.3 0.3-0.5 
Catheter 
maneuverabi-
lity 
Measure with tensile tester in extension 
and compression modes at 100 mm/min Passed 
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Therefore, future iterations of the thrombectomy device should incorporate the use of a 
sheath and a dilator to provide a smooth transition from the diameter of the catheter to the 
tapered tip of the dilator to access the thrombus prior to device deployment.  
 
Conclusion 
A thrombectomy device made with SMP foam and nitinol has been proposed as an 
alternative mechanical thrombectomy treatment for the 95% of patients who are unable to 
receive tPA for the treatment of acute ischemic stroke.  Design features such as a shorter 
working length, higher surface area of contact with the thrombus normal to the direction of 
blood flow, and low rubbery modulus in vessel-contacting surfaces, address complications 
associated with most current devices, such as difficult maneuverability, poor clot hold and 
vessel damage.  The ability to recanalize a vessel that was occluded with a 50 mm long blood 
clot in a porcine animal model indicates the potential of this novel thrombectomy device to 
outperform its predecessors.  
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CHAPTER IV  
SMP FOAM FILLING DEVICE: POROUS MEDIA PROPERTIES 
CHARACTERIZATION 
The fabrication of ultra-low density SMP foams with high volume expansion capabilities 
enabled the redesign of the thrombectomy device to the hybrid SMP-SMA device that was 
presented in the previous chapter.  In addition to being utilized as components of the 
thrombectomy device, these SMP foams are being investigated as an alternative aneurysm 
treatment technique to the insertion of embolic coils, e.g., GDCs.  The goal of both 
techniques is the reduction of blood flow into the aneurysm and the subsequent formation of 
a stable thrombus, which results in the isolation of the aneurysm from the vasculature, 
thereby preventing its future rupture [4, 5, 18, 27].  This chapter presents a porous media 
approach to quantify the resistance to flow imposed by the SMP foams and coils imitating 
the geometry of clinical embolic coils.  
 
Introduction 
Despite the thousands of patients who have been treated with the coiling method with 
positive results, there are still considerable limitations to this treatment technique.  The most 
important are incomplete filling of the aneurysm resulting in low coil packing densities, coil 
compaction over time, and coil migration to the parent artery [47-49].  For example in 
aneurysms with diameter greater than 6 mm, the maximum packing density is on average 
21% [50].   
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To overcome these challenges, SMP foams have been proposed as an alternative treatment 
[55, 84, 88, 93, 94].  The main advantage of this method is that SMP foams show up to 70 
times volume expansion, which enables them to be delivered through a microcatheter, while 
possessing the ability to completely fill the aneurysm upon actuation [55, 94].  The flow 
behavior within the treated aneurysm can be further customized by utilizing SMP foams that 
have been mechanically reticulated, i.e., pierced with a needle. This process helps enhance 
the flow through the SMP foams by puncturing residual membranes. 
 
The success of the endovascular treatment of aneurysms begins with the formation of a stable 
thrombus.  It has been known for over 40 years that thrombosis within a treated aneurysm is 
not only due to biochemical reactions, but also due to altered fluid dynamics [4, 27].  Among 
the hemodynamic factors that induce thrombosis, blood stasis is one of the most important 
[18, 27].  Many studies have implemented a porous media approach to model the flow within 
an aneurysm filled with embolic coils with the goal of evaluating thrombosis [95-98].  The 
same approach has been taken for simulations utilizing virtually reticulated SMP foam [99]. 
 
The porous media model that we employed in this study is the Forchheimer-Hazen-Dupuit-
Darcy (FHDD) equation: 
 
  
  
 
 
 
       
                                                           (4.1) 
where   
  
  
 is the pressure gradient across the sample in the direction of flow (Pa/m),   is the 
dynamic viscosity of the fluid (Pa·s), K is the intrinsic permeability (m
2
), vo is the Darcy 
velocity (flow rate divided by cross-sectional area of the sample) (m/s),   is the density of the 
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fluid (kg/m
3
), and C is the form factor (m
-1
). Permeability and form factor are constitutive 
geometrical parameters of the porous matrix and depend on the contributions of viscous drag 
and inertial losses, respectively [100-102].  Thus, the permeability is inversely proportional 
to the surface area of contact between the solid and the fluid, and the form factor is 
proportional to the projected cross-sectional area of the obstructing solid perpendicular to the 
direction of the fluid flow.  In the present study, we compared the permeability and form 
factor of mechanically-reticulated SMP foams to those of mock embolic coils (MECs), which 
are inexpensive, non-clinical coils that approximate the diameter, distribution, and packing 
density of clinical embolic coils.  Strictly from a fluid dynamics perspective, the purpose of 
this work is to evaluate the potential of SMP foams as embolic devices or components of 
embolic devices. 
 
Materials and methods 
Flow system and measuring apparatus 
An in vitro closed flow loop was constructed to produce a measurable pressure gradient 
across either the SMP foam or the MEC sample at a given flow rate (see Figure 4.1).  It was 
comprised of a gear pump (Chemsteel R106, Oberdorfer), a servo motor (750 W M-series, 
Applied Motion Products), a motor controller (BLuAC5-Q, Applied Motion Products), a 
testing chamber, a fluid reservoir of room temperature water elevated by 30 cm above the 
testing chamber, and two high accuracy pressure transducers (PX429-2.5G5V, Omegadyne 
Inc with accuracy rated at + 0.08% of the baseline maximum).  The output voltage of the 
pressure transducers was recorded at 1 Hz through a data acquisition system (USB6251, 
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National Instruments) to a computer disk for 120 seconds.  The flow rate was measured by 
hand using a stop watch (Traceable, VWR) and a graduated cylinder (250 ml capacity).   
 
Two distinct chambers were required for the characterization of both media.  The chamber 
for the SMP foam samples was fabricated from polycarbonate (inlet and outlet) and PMMA 
(body) using the Roland CNC.  As pictured in Fig. 4.2(A), the body of the chamber was 
designed to enclose a sample holder (inner diameter and outer diameter 15.1 mm and 18.9 
mm, respectively), to which SMP foam samples were adhered prior to being tested.  The 
dimensions of the SMP foam samples were chosen such that they were large enough to 
minimize any effects of heterogeneities in their structure.  Using a 3D printer (Fortus 360, 
Stratasys), the sample holders were fabricated with three 4×4 mm pressure port openings, 15 
mm apart of one another.    
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Figure 4.1. Flow system constructed to measure the pressure gradient across SMP foam and 
MEC samples for a given flow rate range. 
 
 
 
 
Figure 4.2. Exploded view of SMP foam chamber with arrows showing how pieces are 
assembled (A) and assembled MEC chamber (B). 
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Only the upstream and downstream pressure ports were utilized in the measurements.  O-ring 
grooves were machined in both the chamber body and the sample holder to ensure repeatable 
chamber alignment and to seal the pressure ports.  A fine mesh (stainless steel 316, 0.1 mm 
wire diameter, 0.4 mm
2
 squares) was installed at the inlet of the chamber to homogenize the 
flow.  
 
The chamber for measurement of MECs was fabricated from polycarbonate using the Roland 
CNC (see Figure 4.2(B)).  A constricting nozzle was machined at the inlet to provide a 
smooth transition from the 20 mm diameter tubing to the 6 mm diameter of the chamber 
lumen, which is within the range of diameters of ISAs [50].  A Fine mesh (stainless steel 316, 
0.1 mm wire diameter, 0.4 mm
2
 squares) was installed downstream of the nozzle to 
homogenize the flow.   Two pressure ports 50 mm apart were utilized to connect the pressure 
transducers.  A coarse mesh (stainless steel 316, 0.25 mm wire diameter, 2.3 mm
2
 squares) 
was installed between the coil location and the second pressure transducer to hold the MECs 
in place during the test.  The pressure gradient across this mesh was subtracted from the 
pressure gradient data for each MEC sample.    
 
Sample preparation 
Two SMP foams with different cell sizes were evaluated in this study.  They were labeled as 
foam S, for small average cell size, and L, for large average cell size (see Figure 4.3).  They 
were made following the same chemistry and cleaning protocol as the foams described in the 
previous chapter.  Foam S had a Tg, measured by DSC, of 59.1  C, an average cell size of 0.7 
mm and a porosity of 98%.  Foam L had a Tg by DSC of 55.6  C, an average cell size of 1.1 
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mm and a porosity of 98% (refer to [55] for porosity calculation).  The samples were cut 
from a large piece of dried  MP foam using a drill press  ith a ¾” hole sa  attachment   
Then, the appropriate length was achieved by cutting it with a straight edge razor.  The 
resulting SMP foam samples had a diameter of ~16 mm and a length of 49 mm.  For 
mechanical reticulation, the SMP foam samples were perforated utilizing a stainless steel 
acupuncture needle (Kingli) with a diameter of 0.3 mm.  In order to achieve mechanical 
reticulation in a repeatable manner, we 3D printed a hollow cylinder with a cap and utilized it 
as a template guide. The hollow cylinder had 1600 radial holes and 124 axial holes with a 
hole diameter of 0.9 mm and was designed so that the SMP foam samples fit securely within 
it during reticulation.  Four scenarios of mechanical reticulation were produced, and they are 
reported as a function of hole density (ζ), i e , the number of holes pierced per unit area of the 
surface of the SMP foam sample.  The resulting hole densities were 0.9, 1.7, 3.5 and 6.9 
E+05 holes/m
2
.  In all four cases, the pierced holes were evenly distributed along the surface 
of the SMP foam sample.  Figure 4.3 illustrates a true-scale representation of the four hole 
densities overlaid on each foam type, and Figure 4.4 shows the piercing patterns that were 
followed.  Following mechanical reticulation, the SMP foam samples were fixed to the 
sample holders by being crimped to a diameter of roughly 8 mm and then allowed to expand 
inside the sample holder, which had been evenly coated with a thin layer of water resistant 
epoxy (Marine Epoxy, Loctite).  The epoxy was allowed to cure for at least 2 hours prior to 
beginning each test.  Since long term exposure to water can potentially affect the mechanical 
properties of the SMP foams, data were acquired at 0, 2, and 4 hours of water exposure times 
[55, 89].   
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Figure 4.3. SMP foams prior to mechanical reticulation (2.5× magnification) and true-scaled 
overlaid illustrations of the four scenarios of mechanical reticulation and their corresponding 
hole densities.  Hole density is calculated by dividing the number of holes pierced over the 
surface area of the 3D-printed template. 
 
 
 
 
Figure 4.4. Pattern of holes pierced in each of the four scenarios of mechanical reticulation.  
Resulting radial and axial hole densities were approximately the same. 
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MEC samples were prepared by randomly coiling different known lengths (i.e., 0.28, 0.47, 
0.59 and 0.71 m) of copper wire with a diameter of 0.39 mm, which is near the center of the 
range of commercially available embolic coil diameters [5].  Each MEC sample was then 
packed inside the measuring chamber one at a time as shown in Figure 4.5.  Packing density 
(η) was calculated as the ratio of the volume of the coil to the cylindrical bounding volume of 
the coil mass.  The achieved packing densities were 11, 16, 23 and 28%.   
 
 
 
Figure 4.5. Packed MECs in measuring chamber.  Packing density is calculated by the ratio of 
the coil volume to the cylindrical bounding volume of the coil mass. 
 
 
Sample characterization 
For each sample, we implemented a second-order least squares fit to the data of pressure 
gradient plotted against Darcy velocity.  Then we calculated the values of permeability, K, 
and form factor, C, using Eq. 4.1 (see Appendix B for Matlab code).  A total of nine values 
of v0 and their corresponding pressure gradients were utilized for the calculations.  
Measurements were made to check for hysteresis, which could have been caused by sample 
deformation during testing [102].  To quantify other potential sources of measurement 
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variability arising from the instrumentation, an uncertainty analysis was performed based 
upon the root-sum-squares method (see Appendix B for uncertainty analysis calculation) 
[103, 104]. 
 
The Re of these measurements was defined as the ratio of inertial forces and viscous forces 
(from Eq. 4.1) [100, 105]  
   
     
 
.                                                               (4.2) 
Non-dimensionalization of Eq. 4.1 by     
  yielded 
 
  
  
     
 
 
  
    ,                                                        (4.3)        
where the term to the left of the equal sign is the friction factor, f  [105, 106].  Logarithmic 
plots of friction factor against Re provide information about the flow regime in which SMP 
foams and MECs were tested [107].                 
 
Results 
Plots of pressure gradient against Darcy velocity are shown in Figures 4.6(a,b) and 4.7 for 
SMP foams and MECs respectively.  There was no evidence of compression-induced 
hysteresis for either media.  Additionally, moisture uptake from water exposure of the SMP 
foams had little, if any, impact on the measured quantities.  Therefore, data from all water 
exposure times were used in the least squares fits for the SMP foams.  For all the regressions, 
the coefficients of determination for both media were greater than R
2
=0.99. 
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(a) 
 
Figure 4.6. Pressure gradient versus Darcy velocity (v0) of SMP foam S (a) and L (b)  (hole 
density  ζ  ith units  + 5 holes/m2    As the hole density increases, the pressure gradient 
across the samples decreases for both SMP foam types. 
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(b) 
 
Figure 4.6. Continued. 
 
 
For the SMP foams, the pressure gradient at v0_max of foam S was 173E+03 Pa/m and that of 
foam L was 182E+03 Pa/m for the samples with the least amount of mechanical reticulation 
(i.e., ζ=0.9E+05 holes/m2). As hole density was increased to 6.9E+05 holes/m2, the pressure 
gradient at v0_max decreased to 102E+03 and 108E+03 Pa/m for foams S and L respectively. 
For the MECs with η=28%, the pressure gradient at v0_max was169E+03 Pa/m and it 
decreased to 58.0E+03 Pa/m for η=11%.  
 96 
 
 
 
Figure 4.7. Pressure gradient versus Darcy velocity (v0) of MECs (packing density  η    The 
higher the packing density of the MECs, the higher the pressure gradient across them. 
 
 
Plots of permeability and form factor are shown in Figures 4.8 and 4.9 respectively.  The 
differences in permeability and form factor for the SMP foams as a result of varying the 
average cell size were not as pronounced as those resulting from varying the amount of 
mechanical reticulation.  As would be expected, higher amounts of mechanical reticulation 
resulted in overall higher permeability and lower form factor values.  For foam S, 
permeability values ranged between 5.70E-09 and 12.4E-09 m
2
, and form factor values were 
between 2.72E+03 and 7.26+03 m
-1
.  For foam L, permeability and form factor values ranged 
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from 3.25E-09 to 11.5E-09 m
2
 and 2.80E+03 to 6.19+03 m
-1
 respectively. For the MECs, 
there was a change of one order of magnitude in permeability and form factor for samples 
with η=11% versus samples with η=28%; permeability and form factor ranged from 40.5E-
09 to 561E-09 m
2
 and 0.0409E+03 to 0.296E+03 m
-1
 respectively. 
 
Figure 4.8 depicts additional permeability data for embolic coils (diameter of 0.25E-3 m) that 
were considered in the simulations of Kakalis et al. (2008) [95].  In their study, the Kozeny 
theory was implemented to calculate the permeability of embolic coils using the porosity and 
specific surface, which is the total interstitial surface area per unit bulk volume of the porous 
medium [95, 107].  These calculated permeability values follow a similar trend to that of the 
MECs, but are on average four times smaller.  When the measured permeability and form 
factors are used to non-dimensionalize the pressure gradient and Darcy velocity, the resulting 
friction factors and Reynolds numbers for both SMP foams and MECs collapse onto the 
relationship specified by Eq. 4.3 for Reynolds numbers ranging from approximately 1 to 35 
(Fig. 4.10). 
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Figure 4.8. Permeability of SMP foams and MECs. The permeability of the MECs is higher 
than the permeability of both SMP foam types in all cases.  Decreasing the packing density 
results in a decrease in permeability.  Similarly, decreasing the number of holes pierced (i.e., 
decreasing the hole density) also results in a decrease in permeability.  The permeability data 
for embolic coils that was calculated using the Kozeny theory by Kakalis et al. follows the same 
trend as our measured data. 
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Figure 4.9. Form factor of SMP foams and MECs.  The form factor of both SMP foam types is 
higher than that of the MECs in all cases, and it increases as the hole density of the SMP foams 
decreases and as the packing density of the MECs increases.   
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Figure 4.10. Friction factor versus Re for SMP foam samples and MECs.  The friction factors 
and Reynolds numbers for both SMP foams and MECs collapse onto the relationship specified 
by Eq. 4.3 for Reynolds numbers ranging from approximately 1 to 35.  The friction factors of 
all SMP foam samples are higher than those of the MECs. 
 
 
Discussion 
The goal of the state-of-the-art treatment of aneurysms is to prevent the flow of blood into 
the aneurysm by filling it with embolic coils.  Because of biochemical reactions and altered 
hemodynamics, thrombosis is initiated within the coiled aneurysm, and over time, scar forms 
[5, 18, 27].  The biochemical and hemodynamic factors that influence thrombosis go hand in 
hand.  For example, high flow shear stresses activate platelets that subsequently secrete 
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procoagulants and aggregate.  Similarly, areas of turbulence and flow stagnation 
characterized by low shear and long retention times also activate and aggregate platelets 
[108].  Flow stagnation is one of the most important hemodynamic factors that promote 
thrombus formation within an aneurysm [18].  The current study demonstrates that SMP 
foams impose a greater resistance to flow compared to MECs and would therefore be more 
effective at producing these desired post-treatment hemodynamics.  We do not observe 
hysteresis in the pressure gradient versus flow speed data, an effect which would be 
indicative of sample deformation during the test.  Therefore, the higher friction factors for the 
SMP foams arise from a larger contact surface area and projected area that produce greater 
viscous and inertial losses, respectively, relative to those of MECs. 
 
The porous media theory described in this study has been previously used to measure the 
geometrical parameters of polyurethane foams and fibrous porous media [109-113].  
Additionally, blood flow through aneurysms treated with either embolic coils [95-98] or 
SMP foams [99] has been simulated utilizing porous media models.  Major differences 
between these various studies are the selection of the porous media model, the definition of 
the Re, the flow regime of the experiments, and the fluid type.  Some authors limit their flow 
range to the Darcy regime and define Re based on the cell size [110, 114], while others use 
different porous media models, such as the Kozeny theory [95, 98].  The greatest challenge 
of this type of model is that it requires the characterization of additional constitutive 
parameters, such as the specific surface and, in some cases, the flow tortuosity [112].  
Another drawback specific to the Kozeny theory is that it does not take into account the 
diverging or converging nature of the flow within the porous medium.  This is one possible 
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reason for the differences between the embolic coil permeability values of Kakalis et al. and 
those measured for MECs [95, 107]. 
 
One of the main limitations in this study is the selection of the Newtonian working fluid, 
which does not exhibit the shear thinning behavior of blood at small shear rates.  Even 
though it is well documented in the literature that permeability and form factor are intrinsic 
geometrical parameters of the porous medium, experiments should be performed in order to 
validate this statement for the use of blood [100, 102, 107].  Nonetheless, Sorteberg et al. 
observed marked similarities in pressure and fluid dynamics within a bench-top aneurysm 
model packed with coils using blood versus saline solution as the working fluid [115].  In 
addition, Ortega et al. found nearly identical permeability and form factor values for both 
Newtonian and non-Newtonian viscosity models when simulating the flow of blood through 
virtually-reticulated SMP foam at Re ranging between 0.2 and 2.7 [99].  Thus, within this 
range of Re, the permeability and form factor values from the present study may be 
applicable for non-Newtonian blood flow within foam- or coiled-filled aneurysms.   
   
Conclusion 
We have reported in vitro experimental measurements on the porous media properties of 
mechanically-reticulated SMP foams and MECs.  For the reticulation and coil packing 
densities evaluated in this study, SMP foams impose a larger flow resistance than MECs.  
From a perspective in which only the fluid dynamics are considered, these results suggest 
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that SMP foams will be more effective than embolic coils at inducing flow stagnation within 
a treated aneurysm. 
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CHAPTER V  
CONCLUSIONS AND FUTURE WORK 
Over the last century, parallel advancements primarily in the fields of medical imaging and 
materials science, have spurred the progress of neuroendovascular medical devices.  Its 
capabilities have been further broaden by the emergence of smart materials, such as nitinol 
and SMPs, which provide the shape changes necessary for catheter delivery.  This 
dissertation focused on the design, fabrication and testing of neuroendovascular devices 
made with shape memory materials for the treatment of stroke.  
 
Fifteen million people suffer stroke each year worldwide, out of which five million are 
permanently disabled, rendering this disease the leading cause of adult long term disability.  
Commercial neuroendovascular devices for the treatment and prevention of stroke are 
available; however, their use is associated with severe complications that often lead to 
treatment failure and in some cases, patient death.  The motivation for the work presented in 
this dissertation was to provide alternative solutions through the use of novel shape memory 
materials.   
 
Commercially available thrombectomy devices are mainly limited by their deployment 
length as well as their potential for thrombus dislodgement during treatment.  Chapter I 
presented the first attempt at creating a device with a shorter deployment length and a greater 
surface area of contact for improved thrombus hold.  A flower-shape design that crimps to a 
cylinder was adopted, and prototypes were fabricated from crosslinked acrylic thermoset.  
Different crosslink densities, 5, 15, 25 and 35 mole % crosslinker, were evaluated with the 
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goal of maximizing the recovery stress of the devices to ensure thrombus hold.  We 
performed constrained recovery experiments on the machined devices to quantify the 
increase in recovery stress as a function of crosslinker amount, and there was a change of one 
order of magnitude between the 5 and 15 mole % crosslinker devices.  Although the devices 
with the two highest crosslink densities resulted in even higher recovery stresses, they 
devices broke during the constrained recovery experiment as a result of material limitations.  
While increasing crosslink density results in increases in recovery stress, it also reduces the 
strain capacity of the material.  Limited strain and machining defects were probably the 
reason why the highest crosslinked devices failed.  The devices with the two lowest crosslink 
densities were tested in a bench-top thrombotic model with flow, and the effectiveness of 
increasing the crosslink density from 5 to 15 mole % crosslinker was demonstrated by a 
success rate increase from 0 to 67%, respectively. 
 
During the bench-top thrombus removal experiments it was observed that this device had the 
potential of being off-centered with respect to the vessel lumen after shape recovery, 
resulting in device-vessel gaps, through which the thrombus could escape.  The need for a 
design re-evaluation became glaring, giving rise to a novel concept of the thrombectomy 
device involving SMP foam and nitinol, which was discussed in Chapter II.  This version of 
the thrombectomy device is referred to as SMP-SMA, or hybrid thrombectomy device, 
because it exploits the benefits of both types of materials: the high volume expansion rate of 
SMP foams, and the high modulus of nitinol.  After arriving at a design that was most 
feasible from a device performance and fabrication perspectives (see Appendix A for 
previously attempted iterations), design requirements were delineated based on the user 
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needs and predicate device data.  Appropriate tests were then carried out to verify that the 
design met the set specifications.  The fabricated device was only 12 mm in length, compared 
to 20-30 mm for commercially available stent retrievers.  Additionally, the results of all 
verification tests were within the accepted range and the device showed a 100% success rate 
in 9 bench-top thrombus removal experiments with flow.  Final proof-of-concept validation 
was possible through an acute porcine model, in which the device was able to re-establish 
blood flow in an artery occluded with a thrombus nearly 3 times its length.  
 
The chemistry of the SMP foam that was utilized in the hybrid thrombectomy device was 
initially designed for embolic applications.  The current state-of-the-art treatment of ISAs is 
the insertion of embolic coils with the primary goal of forming a thrombus that then leads to 
the isolation of the aneurysm from the vasculature thus reducing the likelihood of rupturing.  
However, with this treatment method it is difficult to achieve complete aneurysm filling, and 
over time, coils tend to compact resulting in the need of treatment repeats and in some cases, 
aneurysm rupture, after which there is only a 50% chance for survival.  One of the main 
driving factors of the formation of a thrombus in a coiled aneurysm is hemodynamics, in 
particular longer residence time or flow stagnation.  Therefore, in Chapter IV we took a 
porous media approach to study how the geometry of the SMP foams affected thrombosis 
within a treated aneurysm compared to non-clinical, inexpensive copper coils mimicking the 
geometry of embolic coils.  The parameters that were investigated were permeability and 
form factor, which are correlation coefficients related to the viscous and inertial losses, 
respectively.  Our results showed that the permeability of the SMP foams was one order of 
magnitude lower than that of the MECs, and their form factors were up to two orders of 
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magnitude higher.  From this data it was concluded that the geometry of the SMP foams 
provides a better environment for fluid stagnation compared to the geometry of the MECs, 
suggesting that SMP foams would enhance thrombosis within a treated aneurysm compared 
to embolic coils.   
 
This study was limited by the use of water as the working fluid.  Even though permeability 
and form factor are theoretically independent of fluid properties, further experiments must be 
performed in order to validate these results with the use of blood.  Given that it is difficult to 
implement a bench-top flow system with blood as the working fluid without having 
confounding effects of thrombosis within the pressure ports, a possible way to validate these 
results would be to subject the SMP foam samples and MECs to gravity-fed blood flow.  By 
keeping the level of blood in the reservoir at a constant height, repeatability of the 
experimental conditions can be ensured between each sample.  After a certain amount of 
time, samples can then be further investigated by means of SEM and weight measurements to 
compare the amount of thrombosis in both types of porous media. 
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APPENDIX A 
NITINOL COMPONENT DESIGN ITERATIONS: FROM MECHANICAL NITINOL 
FLOWER (MNF) TO SNF 
The first prototyping attempt of the SMP-SMA hybrid thrombectomy device concept 
consisted of feeding four nitinol wires (0.1 mm diameter) through a stainless steel microband 
and soldering them at the distal tip of a center wire (0.25 mm diameter) as pictured in Figure 
A1.  This version of the nitinol component was termed mechanical nitinol flower (MNF) 
because the actuation to the flower shape was achieved by pulling the center wire, relying on 
the nitinol’s pseudoelastic beha ior to reco er its original shape upon unloading.  While this 
method was an attractive solution to the lack of equipment with nitinol machining 
capabilities such as an excimer laser, it had three major flaws: size, actuation load and 
aesthetics.  The smallest catheter size through which this device could be delivered was 6 F, 
thus miniaturization was not possible.  Also, the load required for the mechanical actuation of 
the nitinol flower was higher than the load required to compress the foam axially (see Figure 
A2).  Given the scale of the components, the fabrication of this prototype in a manner that 
was pleasing to the eye was difficult to achieve. 
 
In an attempt of reducing the load required for the actuation of the MNF, the wires were 
subjected to heat treatments.  It has been shown that when nitinol is exposed to heat for 
prolonged periods of time, a precipitation reaction occurs that increases its austenitic finish 
transformation temperature.  This shift also causes a decrease in the upper loading plateau, 
defined as the tensile stress at  % strain according to the standard test method for “Tension 
testing of nickel-titanium superelastic materials” (A TM F2516-07E2 ).  The upper loading 
 116 
 
 
plateau is also the stress required to induce crystal transformation from austenite to 
martensite.  Therefore, the reduction in the upper loading plateau after heat treatment yields 
wire that is more compliant at room temperature [85].   
 
 
 
Figure A1. First prototype of the SMP-SMA thrombectomy device made assembled with the 
nitinol wire-based MNF and crimped SMP foam. 
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Figure A2. Axial compression of MNF and SMP foam in 37  C water. 
 
 
Figure A3 shows the stress-strain curves of two nitinol wires (0.1 mm diameter) that were 
tested following ASTM F2516-07E2, one untreated and the other one after it had been 
treated at 550  C for 180 minutes.  This heat treatment resulted in a reduction in the upper 
loading plateau from 575.5 to 169.9 MPa along with a significant decrease in shape memory.  
Upon unloading at 6% strain, the control was able to recover 6% strain, while the heat treated 
wire only recovered 1% strain.  This loss in shape memory was also observed in devices 
made with heat treated wire at 550  C for 60 and 120 minutes as pictured in Figure A4 before 
and after axial compression.  Only the wires in the control device fully recovered their shape. 
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Figure A3. Tensile properties of untreated nitinol wire (0.1 mm diameter) as well as treated 
wire at 550  C for 180 min. 
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(a) 
 
(b) 
 
Figure A4. MNFs assembled with control wire and heat treated wire at 550  C for 60 and 120 
min before (a) and after (b) axial compression. 
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It is evident that no further improvements could be made on the first prototyping method of 
the MNF.  Therefore, we resorted to a method that utilized equipment with nitinol machining 
capabilities.  The resulting prototype is shown in Figure A5.  Four 3 mm long slits were 
machined with an excimer laser every 90  on nitinol tube (0.41 mm outer diameter, 0.33 mm 
inner diameter).  This version was still termed MNF because the actuation method was 
intended to be mechanical as well.  However, with this iteration, miniaturization was 
possibile, but the load required for actuation of the machined MNF was still higher than the 
load required to axially compress the AMP foam.  Figure A6 shows that a peak load of 1.9 N 
is required to achieve maximum reversible deformation of the excimer machined MNF.  This 
load is roughly one order of magnitude higher than the load required to axially compress 
SMP foam to 80% (see Figure A7). 
 
 
 
Figure A5. Un-actuated laser-cut MNF with crimped SMP foam. 
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Thus, there was a risk of SMP foam slippage during thrombectomy because the SMP foam 
would be fully compressed while the MNF would still be in its unactuated geometry.  
Therefore, with this design iteration, the MNF did not serve its purpose: to retain the foam 
during compression.  It is for this reason that the third and final iteration was the pre-setting 
of the nitinol flower shape thermally.  
 
 
 
Figure A6. Force required for axial compression of the laser-cut MNF and resulting diameter 
diameter expansion.  
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Figure A7. Force required for axial compression of SMP foams S, M and L. 
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APPENDIX B 
POROUS MEDIA CHARACTERIZATION SYSTEM MANUAL 
Introduction 
This manual contains details about the components; both purchased as well as machined in-
house, and operation instructions for the Porous Media Characterization System in the 
Biomedical Device Laboratory.  This system is intended to measure the pressure gradient 
across a porous sample as a function of fluid flow.  By fitting the data of pressure gradient 
versus fluid velocity to a second order function by means of a least squares fit, the 
parameters of the Forchheimer-Hazen-Dupuit-Darcy (FHDD) (Eq. 1) can be calculated.  
 
 
  
  
 
 
 
       
 .                                                           (B1) 
 
These parameters are permeability (K) and form factor (C), and provide information about 
the energy losses resulting from viscous and inertial effects respectively.  The same system 
can be utilized to fit the data to a different porous media model; however, appropriate 
changes to the selection of the flow rate range and Matlab code must be made. 
 
Components 
The actual experimental setup is pictured in Figure B1.  The flow loop is comprised of a gear 
pump (Chemsteel R106, Oberdorfer), a servo motor (750 W M-series, Applied Motion 
Products) (see Figure B2), a motor controller (BLuAC5-Q, Applied Motion Products) (see 
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Figure B3), a testing chamber, a fluid reservoir elevated by 30 cm above the testing chamber, 
a data acquisition (DAQ), and two high accuracy pressure transducers (PX429-2.5G5V, 
Omegadyne Inc with accuracy rated at + 0.08% of the baseline maximum) powered by a 
voltage source at 24 V (see Figure B4). The transducers have a flush system connected to 
them as pictured in Figure B5.  
 
 
 
Figure B1. Actual experimental setup. 
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Figure B2. Servo motor and gear pump assembly. 
 
 
 
 
Figure B3. Motor controller and surge protector. 
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Figure B4. Transducer voltage supply and data acquisition electronics. 
 
 
The two chambers described in Chapter 4 are available for this system.  A component of the 
foam chamber is the 3D gasket, which is made with two Vitron o-rings (dash # 216), two 
pieces 6.2 mm long of o-ring cord, a 2 mm biopsy punch and clear urethane glue.  Two holes 
are punched on both gaskets at   and 9 o’clock, and the o-ring cord is first immersed in the 
urethane glue and then inserted inside one of the holes until the end of the o-ring cord is flush 
with the punched o-ring.  The opposite end of the o-ring cord is then adhered in the same 
manner to the second o-ring.  The same procedure is done for the second o-ring cord.  The 
final product should look like the gaskets pictured in Figure B6. Allow the urethane glue to 
cure for two hours.  Replace the gasket if leaks are observed. 
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An engineering drawing of the sample holder is shown in Figure B7.  Four o-rings (dash # 
016) are required for each sample measurement.  The part number and vendor of this item, as 
well as other consumables and parts that area likely to be replaced, are listed in Table B1.  
 
 
 
Figure B5.  Transducer air flush system. 
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Figure B6. Custom 3D gaskets. 
 
 
 
 
Figure B7. Drawing of sample holder. 
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Table B1. List of parts, part numbers and vendors. 
Component of: Part description Part number Vendor 
Chambers and transducer 
flush system 
Brass miniature quick connect 
fitting  
B-QM2-D-
200 Swagelok 
Coil chamber Coarse mesh 9238T56 McMaster 
Coil chamber Fine mesh 9230T454 McMaster 
Coil chamber Air bleed valve 4886K52 McMaster 
Transducer flush system 1/16" ID PTFE tube 0000089761 Zeus 
3D gasket 216 o-ring 9464K37 McMaster 
3D gasket 2 mm diameter o-ring cord 9679K12 McMaster 
Sample holder 016 o-ring 2418T122 McMaster 
 
 
Operation instructions 
The approach to set up the computer interface, load the sample into the measuring chamber, 
select the range of flow rates for the experiment, acquire data, and the basics about data 
interpretation are listed in the following subsections. Special care must be taken when 
measuring an unknown sample for the first time, because it might be too impervious for the 
transducers that are currently on the setup. If this were the case, new transducers able to 
appropriately resolve the pressure generated by the sample would be required. Important: 
always check that all the hose clamps are tight prior to enabling flow. 
1. Setting up the computer interface 
a. Turn on all equipment, including pump power source, DAQ system, and 
power supply (set voltage to 24 V) 
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b. Begin by setting up the folder where the data is to be stored. Name the folder 
the run number from start to finish (for example, for runs 1-5, the folder name 
 ould be ‘runs1-5’) 
c. Copy into this folder the run matrix and Matlab program file 
d. Rename the run matrix to include the data taker’s initials and the date in the 
follo ing format: ‘runmatri _initials_ ayMonthYear’ (for John  mith on 
January 1
st
 2   , the file name  ould be ‘runmatri _J _1January2   ’) 
e. Rename the Matlab program to include the name of the current runs being 
performed 
f. Open the run matrix, Matlab program, Labview program, Q Programmer, and 
a new windows explorer window 
g. In the run matrix, fill in all possible starting information including the date, 
the run numbers, working fluid, foam sample name, foam sample length, and 
foam sample diameter 
h. In the Matlab program, change the run matrix file name in row 38 to the same 
name as the edited run matrix. Set variables a and b on rows 22 and 23 to 
equal your first run number (for runs 1434-1435, a and b would be set to 1434 
for the first run. Then, b will be changed to 1432, 1433, 1434,and 1435 for 
runs 1432, 1433, 1434, and 1435 respectively). Comment out (ctrl+t) rows 41-
44 as seen in Figure B8. 
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Figure B8. Matlab code and rows (#41-44) that are to be commented out for all runs except the 
last one. 
 
i. In the Labview program, right click on the DAQ program box and select 
properties. Set the file save location to the folder created for this set of 
experiments 
j. Open the newly opened windows explorer window to the folder created for 
this set of experiments 
k. Arrange the relevant windows like those in Figure B9: 
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Figure B9. Windows of all programs that are utilized when collecting data. 
 
 
2. Loading the sample (using chamber depicted in Figure B10) 
a. Roll the 4 small o-rings (dash # 016) around the sample holder, one into each 
groove 
b. Place the sample holder o-rings into the grooves located on one side of the 
testing chamber. Rotate the sample holder until the square openings in the 
sample holder are aligned with the pressure transducer ports on the outside of 
the chamber 
c. Place the 3D gasket into grooves located along the length of the chamber side 
where the sample was inserted as depicted in the image below. To minimize 
possible leakages, put a layer of Teflon tape over top of the gasket length that 
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will be inside the chamber, leaving a short piece on the end that can wrap 
around the gasket on the outer surface of the chamber half as shown in Figure 
B10 below 
 
 
 
Figure B10. Application of Teflon tape over 3D gasket prior to chamber assembly to minimize 
possible leakages.  
 
 
d. Interlock the empty half of the testing chamber onto the side loaded with the 
sample and gasket. Wrap the protruding piece of Teflon tape around the 
gaskets located on the outer faces of the chamber. Place the screws that came 
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with the chamber into the center holes on opposite sides of the chamber and 
loosely tighten, just enough to hold the sides of the chamber together. 
e. Loosely tighten each of the other four screws after they are placed into their 
respective holes. 
f. Begin tightening each individual screw slowly, being careful to maintain a 
reasonably uniform amount of tightness in all screws. Continue tightening 
until all screws are secure. Be careful not to over tighten as this could lead 
to cracking of the chamber.  
g. Place the nozzles on the appropriate sides of the chamber body, with the inlet 
nozzle (marked  ith an ‘I’ in sharpie) on the inlet side of the sample  Make 
sure the excess Teflon is wrapped over the gasket. 
h. Attach screws in opposite corners on one nozzle and loosely tighten. Attach 
the other two screws and tighten to the same amount as the first two screws. 
Begin slowly tightening each screw until all screws are secure. Again, 
maintain a uniform amount of tightness in all screws. Do not over tighten. 
i. Repeat h for the nozzle on the other side of the chamber body. 
Note: if the chamber is leaking it is likely because the screws are not tight enough. Adjust as 
necessary. It is best to tighten as required than breaking the chamber by over tightening it 
before loading it to the flow system, which will be discussed in the next subsection. 
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3. Attaching loaded chamber to flow system 
a. Begin by making sure which side of the chamber is the inlet. Position the 
chamber such that it can be accessed quickly for the next step. 
b. Open the upstream valve and wait for the water to fill the entire upstream 
tube. Take the inlet nozzle of the sample chamber and insert it into the 
upstream tubing, making sure that no air is left in the tube to form bubbles. 
Position the chamber vertically to remove bubbles, and gently tap the chamber 
if needed. Once there are no visible bubbles, bring the chamber back to a 
horizontal position and orient the pressure transducer openings parallel to the 
bench top surface as shown in Figure B11. 
c. Let the chamber fill up with water until it is coming out of the downstream 
nozzle. 
d. Partially open the downstream, valve to allow the water in the tubing 
connected to the reservoir to come out. Quickly insert the outlet nozzle of the 
chamber into the outlet tubing, being careful not to trap any air within the 
flow setup. 
e. Move the small black clamps into pace around the tubing surrounding the 
nozzles on either side. There should be two clamps per nozzle. Use the 
channel locks to tighten the clamps into place. Do not over tighten the 
clamps, as it might crack the chamber. 
f. Fully open the downstream valve. 
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g.  et the starting pump speed by typing in ‘J   1’ and hitting enter into the Q 
Programmer. This command instructs the motor to set the jogging speed at 0.1 
re olutions per second (RP )  Then start the pump by typing ‘ J’ into the Q 
Programmer (make sure both the upstream and downstream valves are 
open!)   lo ly increase the speed of the pump by typing ‘     ’ into the Q 
Programmer, then ‘    5’, increasing until ‘  1  ’ is reached  
h. Wait until water begins to flow back into the fluid reservoir. 
i. Record the time at which the sample was fully exposed to water in the 
appropriate location in the run matrix 
j. Attach the pressure transducers to the quick connect adapters on the sides of 
the sample chamber, being sure to connect the upstream transducer to the 
upstream pressure port and the downstream pressure transducer  to the 
downstream pressure port. 
k. Open the air bleed valves on the pressure transducers. Remove each one from 
its cradle and tap vigorously on the brass portions of the transducer with the 
channel locks to disturb air bubbles. Bubbles exiting the air bleed valve 
should be visible. Tap the T connectors and transducer lines to make sure all 
bubbles are being flushed out. Tilt the transducer in all directions while 
tapping to ensure removal of bubbles from all areas. Cover the air bleed valve 
outlet  ith a paper to el to “catch” the  ater   oing this  ill a oid the 
transducer wiring from getting wet.  Repeat this step for both transducers. 
Replace the transducers in the cradle and secure them in place. Close the air 
bleed valves. 
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l. Figure B11 shows the final assembled and connected chamber 
 
 
 
Figure B11. Assembled chamber in horizontal position after flushing air bubbles out. 
 
 
m. Fill water reservoir up to black line on the side indicating standard filling 
height. Use RO water. 
 
 
 138 
 
 
4. Find maximum motor speed 
a. Slowly begin ramping up the motor speed (intervals of 0.1-0.5 RPS) by using 
the CS command in Q programmer (for a speed of 1 5, type ‘  1 5’)  
Continue ramping up the motor speed until the analog pressure gauge 
measures 2.5. 
b. At this point start the Labview code by pressing the black arrow on the 
commands bar. A window will pop up asking you to input a file name. Save 
this file as test1. Allow the program to run for 10 seconds before pressing the 
red stop sign button on the Labview program. 
c. Open the newly created file. In column F, row 24, make a formula to calculate 
the pressure being measured at the upstream transducer. Use the calibration 
equation supplied in line 71 of the Matlab code and the value in column C, 
row 24 as the voltage value (Do not use the part of the Matlab equation 
multiplying the sample by 6894.76, that is the conversion factor for Pascals, 
the equation entered should be  =0.488*V-0.08, with V being the voltage 
found in the test page). This will give the pressure at the upstream transducer 
in pounds per square inch (psi). Copy the formula down column F to view the 
pressure measurements from each time point. 
d. The number in column F will eventually need to be equal to 2.5. Most likely, 
after finding the motor speed that makes the analog pressure 2.5, the pressure 
will be well under 2.5 in the data taken. At this point, increase the motor speed 
in 0.1 RPS intervals until the upstream transducer reads a pressure of 2.5.  
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Note: 2.5 psi is the maximum pressure that both transducers can 
withstand. Do not go over this pressure.   
e.  If the value is less than 2.5, increase the motor speed by a small amount. 
Repeat steps 4b and 4c, naming the file as test2, and once again finding the 
pressure in the test2 file. 
f. Repeat step e until the calculated pressure reading in the test is 2.5, making 
sure to name each new test in incremental order. 
g. Record the motor speed that produces this pressure in the run matrix as the 
RPS for the fifth run being performed. For the first and last runs the RPS 
value should be zero. For the second, third, and fourth runs, the RPS should be 
0.25, 0.5, and 0.75 times the RPS of run 5 respectively. For the sixth, seventh, 
and eighth runs, the RPS values should be 0.75, 0.5, and 0.25 time the RPS of 
run 5 respectively. 
 
5. Data Collection (1st run) 
a. Shut off the pump by gradually reducing the speed in Q Programmer by 
increments of 0.5 until the speed is less than 1, and then use the command ‘ J’ 
to stop the pump. 
b. Close the upstream valve. 
c. Wait two minutes for the water to stabilize. 
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d. Start the Labview program to collect data. Save the name of the file as the 
name of the run you are performing (e.g., for run 4  sa e it as ‘4 ’)  Begin 
timing using a stopwatch as soon as the save box is closed. 
e. Record the time at which the run was started in the run matrix in the 
appropriate column (for example, 1:33 PM) 
f. Record the analog pressure gauge reading in the run matrix. 
g. Record the flow speed, volume measured, and time measured in (All should 
be 0 for the first run) 
h. Wait until 2 minutes have passed on the stopwatch. Do not stop the program 
until at least two minutes have passed. 
i. Stop the Labview program. 
j. Open the data file just created. 
k. Insert into row 22 a new row containing the headers contained in the headers 
file included in the attached files. Simply highlight the row in the headers file, 
hit control C, switch to the data file, select row 22 and right click on its 
number, and select insert copied cells. 
l. Click file, save as, excel workbook, and save the file with the same name as 
the original which will create a new Excel file. 
m. Run the Matlab code by hitting F5. If the data looks uniform continue to the 
next run. Otherwise repeat the current run. 
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6. Data Collection (2nd-8th runs) 
a. Start the pump by typing in JS followed by the RPS speed for the second run 
(for e ample, for a run speed of   5, type ‘J   8’) and hitting enter  Open the 
upstream valve to allow flow to pass through the sample and immediately 
afterwards type in CJ to commence running the motor. 
b. Take a beaker and a stop watch over to the outlet of the tubing into the fluid 
reservoir. Use the beaker to gather fluid, while timing for roughly ten seconds. 
Stop the stopwatch and pull the beaker out of the water stream 
simultaneously. Record the time from the stopwatch in the runmatrix in the 
appropriate column. Leave the beaker off to the side for now, filled with the 
gathered water. 
c. Start the Labview program, saving the file as the next run number. 
Immediately start the stopwatch. 
d. Record the time at which the run was started in the appropriate column. 
e. Pour the fluid from the beaker into a graduated cylinder. Record the volume of 
fluid in the run matrix in the appropriate column. 
f. The flow rate should be calculated in the appropriate column by dividing the 
volume of fluid by the time duration it was measured in, and dividing by 60, 
to give flow in mL/min. 
g. Record the analog pressure gauge reading in the appropriate column in the 
runmatrix. 
h. Change the Matlab code variable b to be the value of the latest run number. 
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i. Wait until at least two minutes have passed on the stopwatch. 
j. Stop the Labview Program. 
k. Follow steps 5j through 5m 
l. Pour the fluid from the graduated cylinder back into the fluid reservoir 
m. Use CS to change the speed to the RPS for the next run. 
n. Repeat steps 6b through 6l for each run until the final run. 
 
7. Data Collection (9th run) 
a.  top the pump by typing in ‘ J’ into the Q Programmer and hitting enter  
Immediately close the upstream valve. 
b. Wait two minutes. 
c. Follow steps 5d through 5l 
d. On the second sheet of the runmatrix, make the make Column A rows 1 
through 9, equal to the run numbers. In Column B and the same rows, make 
these cells equal to the flow rate for the corresponding run numbers. In 
column C and the same rows, make these cells equal to the RPS values for 
each associated run. 
e. Uncomment rows #41-44 and run the Matlab code by hitting F5. 
f. Once data is finished collecting, close the downstream valve, disconnect 
pressure transducers, close and secure the fluid reservoir, Undo clamps, and 
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remove chamber. Open the air bleed valve on the pressure transducers and 
allow the water to drain out. 
 
8. Data Interpretation 
a. On execution of the Matlab code the final time, a graph showing the values 
for K and C will be displayed, along with their respective errors. An example 
graph is shown in Figure B12. 
 
 
 
Figure B12. Example graph of FHDD equation showing values of permeability (K) and form 
factor (C).  
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b. Each iteration of the Matlab code previously displayed the pressure readings 
for all runs taken up to that point. It is important to take note of any wild 
fluctuations or absurdly high or low values being calculated as this indicates 
an error in the setup or execution. Figure B13 is an example of a standard 
pressure reading graph during the runs (Upstream transducer has the higher 
pressure reading, in green): 
 
 
 
Figure B13. Example of standard pressure transducer time history showing the upstream 
transducer (green line) above the downstream transducer (blue line). 
 
 
Matlab code 
clc, close all, clear all 
%% Define all variables: 
%p- pressure, v- velocity, A- cross-sectional area, dx-length between 
%pressure taps, K- permeability, C- form factor, f=-dp/dx 
% From doing the least squares fit and uncertainty analysis, we fit the 
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% function f=-dp/dx=(mu/K)*v+rho*C*v^2 with the line fc=a*v^2+b*v. We find 
% the constants a and b, and then calculate permeability and form factor 
as 
% K=mu/b, C=a/rho. 
%Transducers will be labeled as follows: 
%T_3=400294 wire label 1, excel column 3, daq slot 1, upstream 
%T_1=415375 wire label 3, excel column 5, daq slot 3, downstream 
  
  
%Calibration curves as of after the move: 
%Transducer S/N 59813: P[psi]=2.3182*voltage[V]-15.0383 
%Transducer S/N 59815: P[psi]=2.3278*voltage[V]-14.4580 
  
%**************************CHANGE EACH TIME******************************* 
  
% Do a loop to import raw data 
%set range of file names: 
a=run#x; 
b=run#x+∆x; 
  
%This is the diameter of the black plastic insert piece that goes inside 
%the chamber. Be sure to change this value if the diameter is altered t o 
%get a tighter foam fit. The units are m. 
%Alternatively, if using the GDC chamber, this is the inner diameter of 
the 
%chamber, which is 0.006 m. 
insert_diameter=0.0151; 
  
%dx is the length from the first to the last pressure tap. This value 
%should be usted depending on the chamber used. The new permeability 
%chamber is dx=0.03 m and the gdc chamber is dx=0.05 m. 
dx=0.015; %m 
  
%Enter filename of the run matrix 
str2='run_matrix_Initials_DayMonthYear.xlsx'; 
  
% % Using hand measured flow rates instead of the transducer: 
data2=xlsread(str2,'sheet2'); 
handmeas=data2(1:9,2); %*edit to the correct rows/colums of the hand  
range_vec=[1:9]; 
rps_vals=data2(1:9,3); 
%************************************************************************* 
  
%Multiple files 
  
for i=a:b;  
str= strcat(int2str(i),'.xlsx'); 
eval('data=xlsread(str);'); 
  
%time is in column 1,transducer 400294 voltage in column 3, and transducer 
%415275 voltage in column 5. In the annotated files, the header ends in 
row 
%23, however, this code will consider data starting at row 22, because 
%there is an empty row in the file as exported from labview that matlab 
%doesn't count. Take the average of the first 120 seconds. 
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 time=data(23:143,1); %seconds 
T_1_V(i)=mean(data(23:143,5)); %Volts 
% T_2_V(i)=mean(data(23:143,4)); %Volts 
T_3_V(i)=mean(data(23:143,3)); %Volts 
%Get actual flowrate and pressure values: 
  
%Transducer S/N 400335: P[psi]=0.479*voltage[V]-0.030 
%Transducer S/N 400294: P[psi]=0.488*voltage[V]-0.08 
%Transducer S/N 415375: P[psi]=0.479*voltage[V]-0.037 
  
%Calibration fit for the 0-2 psig transducers: 
% T_2(i)=(0.479.*T_2_V(i)-0.030)*6894.76; %Pa  
T_3(i)=(0.488.*T_3_V(i)-0.08)*6894.76; %Pa, upstream transducer 
T_1(i)=(0.479.*T_1_V(i)-0.037)*6894.76; %Pa, downstream transducer 
  
%f is the vector containing pressure gradient, i.e. T_3-T_1/length.  
  
A=pi*(0.5*insert_diameter)^2; %m^2 
  
%get zero values 
f_zero=(T_3(a)-T_1(a))/dx; %Pa/m 
f(i)=((T_3(i)-T_1(i))./dx)-f_zero; %Pa/m 
  
  
%Plot transducers' voltage history for all runs: 
if i<(a+6) 
    figure (1) 
    subplot(3,2,i-a+1) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
    h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
     print('-dpdf','runsa_b_transducer_time_history_1.pdf') 
elseif (a+6)<=i&&i<(a+12) 
    figure (2) 
    subplot(3,2,i-a-5) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
    h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
         print('-dpdf','runsa_b_transducer_time_history_2.pdf')         
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elseif (a+12)<=i&&i<(a+18) 
    figure (3) 
    subplot(3,2,i-a-11) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
    h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
           print('-dpdf','runs1407_1433_transducer_time_history_3.pdf') 
elseif (a+18)<=i&&i<(a+24) 
    figure (4) 
    subplot(3,2,i-a-17) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
    h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
          print('-dpdf','runsa_b_transducer_time_history_4.pdf')  
elseif (a+24)<=i&&i<(a+30) 
    figure (5) 
    subplot(3,2,i-a-23) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
   h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
         print('-dpdf','runsa_b_transducer_time_history_5.pdf') 
elseif (a+30)<=i&&i<(a+36) 
    figure (6) 
    subplot(3,2,i-a-29) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
    h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
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    set(h_legend,'FontSize',2); 
    hold off 
        print('-dpdf','runsa_b_transducer_time_history_6.pdf') 
elseif (a+36)<=i&&i<(a+42) 
    figure (7) 
    subplot(3,2,i-a-35) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%      plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
   h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
         print('-dpdf','runsa_b_transducer_time_history_7.pdf') 
else 
    figure (8) 
    subplot(3,2,i-a-41) 
    plot(time,(0.479.*data(23:143,3)-0.037),'g','LineWidth',0.5) 
    str='Transducer time history for file name:'; 
    title([str num2str(i)]) 
    xlabel('Time [s]') 
    ylabel(' Pressure [psig]') 
    hold on 
%     plot(time,(0.479.*data(23:143,4)-0.030),'r','LineWidth',0.5) 
    plot(time, (0.488.*data(23:143,5)-0.08),'LineWidth',0.5) 
    h_legend=legend('400294(T_3)','415375(T_1)','Location','SouthEast'); 
    set(h_legend,'FontSize',2); 
    hold off 
         print('-dpdf','runsa_b_transducer_time_history_8.pdf') 
end 
  
end 
 
rho=1000; %kg/m^3 
mu=0.00112; %Pa*s 
dp_dx_all=f(a:b); %Pa/m 
dp_dx=f(a:b); 
  
figure(17) 
scatter(a:linspace(a,b,1),dp_dx.*dx./6894.76) 
title('Pressure drop as a function of run#') 
xlabel('Run #') 
ylabel('Pressure -(dP-dP_0) [psig]') 
hold on 
plot(a:linspace(a,b,1),dp_dx.*dx./6894.76) 
hold off 
     print('-dpdf','runsa_b_pressure_drop.pdf') 
  
% ************************************************************************ 
% measured data 
handmeas=handmeas'; 
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figure(10) 
scatter(handmeas,(dp_dx.*dx./6894.76)); 
title('Permeability data for runs a-b as a function of water exposure 
time') 
xlabel('Flow rate (Q) [ml/min]-handmeasured') % ****^^^^^^^^^^^ CHANGED 
ONLY FOR THESE RUNS ^^^^^^^^^^^^******** 
ylabel('Pressure -(dP-dP_0) [psig]') 
hold on 
plot(handmeas,(dp_dx.*dx./6894.76)) 
plot(linspace(0,max(handmeas),100),0,'k--','linewidth',4) 
hold off 
    print('-dpdf','runsa_b_pressure_handmeasured_flowrate.pdf') 
  
% ************************************************************************ 
  
%Hazen-Dupuit-Darcy equation--> f=-dP/dx=mu/K*v+rho*C*v^2 
%We get an exponential equation of the form: f=av^2+bv, where v is the 
%darcy velocity and a and b are coefficients we get from the least-squares 
%fit analysis. 
%Also, a=rho*C and b=mu/K.  
%******The "h" in front of every variable stands for handmeasured values. 
%Only handmeasured values are considered in this code. 
  
%We only got good data for the the interval (1:14); redefine v and f for 
%inputs 
%range_vec is a vector with the positions that will be used to calculate 
%permeability. Position 1 corresponds to run#a 
  
dp_dx=dp_dx_all(range_vec); 
  
hvel=handmeas*(10^-6)./60./A; %if using handmeasured data 
hvel=hvel(range_vec); 
% hvel=hvel'; 
  
%%%Uncertainty 
%1. Determine hysteresis error: 
% To determine hysteresis error, select runs for hysteresis plot 
%Import RPS value, versus run# 
%load RPS values starting at run#a 
%%__________________change!!!!!! 
  
%%__________________chanage if a:b>100!!!!!! 
rps_vec=zeros(1,1000); 
rps_vec(a:b)=rps_vals; 
%%__________________change!!!!!!! 
runs_hys=[a:b]; 
  
figure(21) 
plot(rps_vals,f(runs_hys).*dx) 
hold on 
scatter(rps_vals,f(runs_hys).*dx) 
ylabel('-dp [Pa]') 
xlabel('Pump RPS value') 
title('Pressure drop vs. RPS value') 
%plot p vs position, and add sigma_p 
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%plot dp_dx vs velocity, and add sigma_dp_dx 
rps_vec_hys=rps_vec(runs_hys); 
p1_hys=T_1(runs_hys); 
p3_hys=T_3(runs_hys); 
%If max RPS value was not measured twice 
for i=1:(length(p1_hys)-1)/2; 
    dif_p1(i)=(p1_hys(i)-(p1_hys(length(p1_hys)+1-i))); 
    dif_p3(i)=(p3_hys(i)-(p3_hys(length(p1_hys)+1-i))); 
end 
sigma_rep=mean(abs([dif_p1,dif_p3])); 
% 2. Get sigma_bias and sigma_prec 
for i=a:b;  
    %reload all data 
str= strcat(int2str(i),'.xlsx'); 
eval('data=xlsread(str);'); 
eval(['data' num2str(i) ' =data']); 
eval(['T_1_' num2str(i) '=','(data' ,num2str(i),'(23:143,5)*0.479-
0.037)*6894.76']);%Pa 
eval(['T_2_' num2str(i) '=','(data' ,num2str(i),'(23:143,4)*0.479-
0.03)*6894.76']);%Pa 
eval(['T_3_' num2str(i) '=','(data' ,num2str(i),'(23:143,3)*0.488-
0.08)*6894.76']);%Pa 
%Uncertainty 
    %sigma_bias=0.1/100*mean(120readings) 
eval(['sigma_bias_1(i)=0.1/100*mean(T_1_' num2str(i) ')']); 
eval(['sigma_bias_2(i)=0.1/100*mean(T_2_' num2str(i) ')']); 
eval(['sigma_bias_3(i)=0.1/100*mean(T_3_' num2str(i) ')']);  
%for zero values 
eval(['sigma_bias_1_zero=0.1/100*mean(T_1_' num2str(a) ')']); 
eval(['sigma_bias_2_zero=0.1/100*mean(T_2_' num2str(a) ')']); 
eval(['sigma_bias_3_zero=0.1/100*mean(T_3_' num2str(a) ')']); 
  
for n=1:120; 
  
eval(['dif_T_1_' num2str(i) '(n)=(T_1_' num2str(i) '(n)-mean(T_1_' 
num2str(i) ')).^2']); 
eval(['dif_T_2_' num2str(i) '(n)=(T_2_' num2str(i) '(n)-mean(T_2_' 
num2str(i) ')).^2']); 
eval(['dif_T_3_' num2str(i) '(n)=(T_3_' num2str(i) '(n)-mean(T_3_' 
num2str(i) ')).^2']); 
%for zero values 
eval(['dif_T_1_zero=(T_1_' num2str(a) '-mean(T_1_' num2str(a) ')).^2']); 
eval(['dif_T_2_zero=(T_2_' num2str(a) '-mean(T_2_' num2str(a) ')).^2']); 
eval(['dif_T_3_zero=(T_3_' num2str(a) '-mean(T_3_' num2str(a) ')).^2']); 
end 
  
% +/-tv,95*sx/sqrt(N). Use t=1.9801 (infinite degrees of freedom), check 
t=1.9801; 
eval(['sigma_prec_1(i)=t.*sqrt(1/(120-1).*sum(dif_T_1_' num2str(i) 
'))/sqrt(120)']); 
eval(['sigma_prec_2(i)=t.*sqrt(1/(120-1).*sum(dif_T_2_' num2str(i) 
'))/sqrt(120)']); 
eval(['sigma_prec_3(i)=t.*sqrt(1/(120-1).*sum(dif_T_3_' num2str(i) 
'))/sqrt(120)']); 
%for zero values 
 151 
 
 
eval(['sigma_prec_1_zero=t.*sqrt(1/(120-
1).*sum(dif_T_1_zero))/sqrt(120)']); 
eval(['sigma_prec_2_zero=t.*sqrt(1/(120-
1).*sum(dif_T_2_zero))/sqrt(120)']); 
eval(['sigma_prec_3_zero=t.*sqrt(1/(120-
1).*sum(dif_T_3_zero))/sqrt(120)']); 
  
% Now we get sigma_p for each run, for each transducer.  
  
sigma_p_1(i)=sqrt(sigma_bias_1(i)^2 + sigma_prec_1(i)^2 ); 
sigma_p_2(i)=sqrt(sigma_bias_2(i)^2 + sigma_prec_2(i)^2 ); 
sigma_p_3(i)=sqrt(sigma_bias_3(i)^2 + sigma_prec_3(i)^2 ); 
%for zero values 
sigma_p_1_zero=sqrt(sigma_bias_1_zero^2+sigma_prec_1_zero^2); 
sigma_p_2_zero=sqrt(sigma_bias_2_zero^2+sigma_prec_2_zero^2); 
sigma_p_3_zero=sqrt(sigma_bias_3_zero^2+sigma_prec_3_zero^2); 
end  
  
sigma_p_1=sigma_p_1(a:b); 
sigma_p_2=sigma_p_2(a:b); 
sigma_p_3=sigma_p_3(a:b); 
sigma_dp=sqrt(sigma_p_1.^2+sigma_p_1_zero.^2+sigma_p_3.^2+sigma_p_3_zero.^
2); 
sigma_dp_dx=1/dx.*sigma_dp; 
 
%Select only the numbers that are considered in permeability calculation 
%using range_vec: 
sigma_dp_dx=sigma_dp_dx(range_vec); 
  
%%Calculating K and C with uncertainty: 
%with handmeasured values: 
par_ha=(sum((hvel.*dp_dx)./sigma_dp_dx.^2)./sum(hvel.^2./sigma_dp_dx.^2)-
((sum((hvel.^2.*dp_dx)./sigma_dp_dx.^2).*sum(hvel.^3./sigma_dp_dx.^2))./(s
um(hvel.^2./sigma_dp_dx.^2).*sum(hvel.^4./sigma_dp_dx.^2))))./(1-
(sum(hvel.^3./sigma_dp_dx.^2).^2./(sum(hvel.^2./sigma_dp_dx.^2).*sum(hvel.
^4./sigma_dp_dx.^2)))); 
hK=mu./par_ha;  
par_hb=(sum((hvel.^2.*dp_dx)./sigma_dp_dx.^2)-
par_ha.*sum(hvel.^3./sigma_dp_dx.^2))./sum(hvel.^4./sigma_dp_dx.^2); 
hC=1/rho.*par_hb; 
  
%calculation of sigma_K and sigma_C: (da stands for partial of a wrt y). 
%All variables with h are for handmeasured values 
  
for i=1:length(range_vec); 
dhK_df(i)=-
mu.*(sum(hvel.^2./sigma_dp_dx.^2).*sum(hvel.^4./sigma_dp_dx.^2)-
(sum(hvel.^3./sigma_dp_dx.^2)).^2).*(hvel(i)./sigma_dp_dx(i).^2.*sum(hvel.
^4./sigma_dp_dx.^2)-
hvel(i).^2./sigma_dp_dx(i).^2.*sum(hvel.^3./sigma_dp_dx.^2))./(sum(hvel.*d
p_dx./sigma_dp_dx.^2).*sum(hvel.^4./sigma_dp_dx.^2)-
sum(hvel.^2.*dp_dx./sigma_dp_dx.^2).*sum(hvel.^3./sigma_dp_dx.^2)).^2; 
dha(i)=(hvel(i)./sigma_dp_dx(i).^2.*sum(hvel.^4./sigma_dp_dx.^2)-
hvel(i).^2./sigma_dp_dx(i).^2.*sum(hvel.^3./sigma_dp_dx.^2))./(sum(hvel.^2
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./sigma_dp_dx.^2).*sum(hvel.^4./sigma_dp_dx.^2)-
(sum(hvel.^3./sigma_dp_dx.^2)).^2); 
dhC_df(i)=1./rho.*(hvel(i).^2./sigma_dp_dx(i).^2-
dha(i).*sum(hvel.^3./sigma_dp_dx.^2))./sum(hvel.^4./sigma_dp_dx.^2); 
end 
sigma_hK=sqrt(sum((dhK_df.*sigma_dp_dx).^2)); 
sigma_hC=sqrt(sum((dhC_df.*sigma_dp_dx).^2)); 
  
%hz becomes a vector containing the calculated dp_dx values 
hz=(mu./hK.*hvel)+(rho.*hC.*hvel.^2); %if using handmeasured data 
  
% Correlation for non-linear regression 
% error vector e=observed values (dp_dx)- fitted values (hz) 
% SSE, sum of squared errors. SSE=summation(dp_dxi-hzi)^2 
% SST, sum of squared totals. SST=summation(dp_dxi-average(dp_dx))^2. 
% R^2=1-SSE/SST. 
hRsq=1-(sum((dp_dx-hz).^2)/sum((dp_dx-mean(dp_dx)).^2)); 
hRsq2=((sum(hz.*dp_dx)-
(sum(hz)*sum(dp_dx))/length(dp_dx))/sqrt((sum(hz.^2)-
(sum(hz))^2/length(hz))*(sum(dp_dx.^2)-(sum(dp_dx))^2/length(dp_dx))))^2; 
  
figure (11) 
plot(sort(hvel),sort(hz),'--k') 
hold on 
aerrorbar=errorbar(hvel(1:9),dp_dx(1:9),sigma_dp_dx(1:9),'ob') 
berrorbar=errorbar(hvel(10:18),dp_dx(10:18),sigma_dp_dx(10:18),'sr') 
cerrorbar=errorbar(hvel(19:27),dp_dx(19:27),sigma_dp_dx(19:27),'^g') 
set(aerrorbar,'MarkerSize',5, 'LineWidth',2) 
set(berrorbar,'MarkerSize',5, 'LineWidth',2) 
set(cerrorbar,'MarkerSize',5, 'LineWidth',2) 
title('FHDD equation runs a-b') 
xlabel('Darcy velocity (v)[m/s]- handmeasured') 
ylabel('-dp/dx [Pa/m]') 
str='K=' 
unc='+/-' 
strr='m^2, C=' 
uncc='+/-' 
strrr='m^-1' 
h_legend=legend([str num2str(hK) unc num2str(sigma_hK) strr num2str(hC) 
uncc num2str(sigma_hC) strrr], '0 hours','2 hours','4 
hours','Location','NorthWest') 
set(h_legend,'FontSize',10) 
text(hvel(4),0,['R^2=' num2str(hRsq)]) 
print('-dpdf','FHDD_eq_runsa_b_errorbars.pdf') 
  
% % get all values in a matrix: 
runsnum=['runs' num2str(a) '_' num2str(b) '.xls']; 
labels1={'dp_dx [Pa/m]', 'sigma_dp_dx [Pa/m]', 'hvel [m/s]'}; 
labels2={'hK [m^2]' 'sigma_hK [m^2]' 'hC [m^-1]' 'sigma_hC [m^-1]'}; 
HDD_vals=[dp_dx',sigma_dp_dx',hvel']; 
KC_vals=[hK, sigma_hK, hC, sigma_hC]; 
xlswrite(runsnum, HDD_vals, 1, 'A5'); 
xlswrite(runsnum, KC_vals,1, 'A2'); 
xlswrite(runsnum, labels1, 1, 'A4'); 
xlswrite(runsnum, labels2, 1, 'A1'); 
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Least squares fit and uncertainty analysis calculation 
Starting with the generalized Forcheimer-Hazen-Dupuit-Darcy Equation: 
        
                                                               (B2) 
With     
  
  
, and     , where 
  
  
 is the particular pressure gradient and   is the Darcy 
velocity, the method of least squares was used to calculate the values of   and  . In order to 
perform the least squares fit analysis, the variable   was defined as: 
  ∑       
                                                            (B3) 
The least squares fit analysis utilizes that the partial derivative of   with respect to   and   
must be zero, which allows for   and   to be calculated: 
 
  
   
 
  
∑  
 
  
           
                         (B4) 
 
  
   
 
  
∑ [
 
  
           
  ]
 
                  (B5) 
With    being the standard deviation of the pressure gradient at the index  . Solving these 
equations for   and   yields: 
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The material constants that we are interested in for our study, K and C, can be determined by 
the following formulas: 
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and 
  
 
 
.                                                   (B9) 
The uncertainty in any gi en function z=m+q+…+n is calculated by computing  
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.                                    (B10) 
Following this method, the uncertainty in each pressure measurement is calculated.  This is 
the compound uncertainty resulting from bias (0.1% reading) and precision (standard 
deviation with  t=1.9801, for unlimited degrees of freedom) errors in each transducer, 
yielding:  
   √     
            
   .                                                  (B11) 
The difference in pressure between the upstream and downstream transducer is calculated as 
follows: 
                     ,                                        (B12) 
where the first subscript is the position of the transducer (1=upstream, 2=downstream) and 
the second subscript is the reading of the transducer (0= the reading at zero velocity). Thus 
    √    
       
      
       
   .                                     (B13) 
The uncertainty in the pressure gradient is 
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   ,                                    (B14) 
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where the second term to the right under the square root is zero assuming there is no 
uncertainty in the measurement of    because this distance was machined precisely using a 
CNC.  
 
To calculate the uncertainty in K and C, it is required to first compute the partial derivatives 
of K and C with respect to y:  
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where the partial derivative of a with respect to y is: 
 
  
   
 
  
  
 ∑[
  
 
  
 ] 
  
 
  
 ∑[
  
 
  
 ]
∑[
  
 
  
 ] ∑[
  
 
  
 ] (∑[
  
 
  
 ])
  .                                                (B17) 
Finally, from Eq. A10 
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 156 
 
 
and 
   √∑[(
  
   
   )
 
].                                                       (B19) 
 
 
